Page last updated: 2024-10-31

metyrapone and Cushing's Syndrome

metyrapone has been researched along with Cushing's Syndrome in 389 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research Excerpts

ExcerptRelevanceReference
"Fifteen patients with endogenous Cushing's syndrome were treated with metyrapone and/or amino-glutethimide."9.05Aminoglutethimide and metyrapone in the management of Cushing's syndrome. ( Adamson, U; Sjöberg, HE; Thorén, M, 1985)
"Steroidogenesis inhibitors such as metyrapone (MTP) and osilodrostat (ODT) have a key role in the medical treatment of endogenous Cushing's Syndrome (ECS)."8.31LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing's Syndrome. ( Balakirouchenane, D; Bertherat, J; Blanchet, B; Bonnet-Serrano, F; Choi, M; Declèves, X; Groussin, L; Khoudour, N; Puszkiel, A; Vasseur, A; Vidal, M, 2023)
"Metyrapone and ketoconazole, frequently used steroidogenesis inhibitors for treatment of Cushing syndrome, can be associated with side effects and limited efficacy."7.91Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study. ( Creemers, SG; de Jong, FH; de Rijke, YB; Feelders, RA; Franssen, GJH; Hofland, LJ; van Koetsveld, PM, 2019)
"Our objective was to assess the efficacy and safety of combination therapy with mitotane, metyrapone, and ketoconazole in severe ACTH-dependent Cushing's syndrome."7.77Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome. ( Baudin, E; Blanchard, A; Brailly-Tabard, S; Chanson, P; Droumaguet, C; Gautier, JF; Jublanc, C; Kamenický, P; Leboulleux, S; Salenave, S; Schlumberger, M; Young, J, 2011)
"We present a case of McCune-Albright syndrome revealed by a Cushing's syndrome treated by metyrapone."7.73[Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome]. ( Azzabi, O; Ben Ammar, B; Ben Hariz, M; Ben Mrad, N; Halioui-Louhaichi, S; Maherzi, A; Nefzi, L, 2005)
"We wished to develop optimal criteria for interpreting the single-dose overnight metyrapone test and to compare the diagnostic efficiency of the overnight and the standard 6-dose metyrapone tests for the differential diagnosis of ACTH-dependent Cushing's syndrome."7.69A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome. ( Avgerinos, PC; Cutler, GB; Nieman, LK; Oldfield, EH, 1996)
"18 patients were studied on 21 occasions: three with Cushing's disease without metyrapone treatment prior to IPSS (M-), 11 with Cushing's disease with metyrapone pretreatment (M+), three with ectopic ACTH syndrome, and one with pseudo-Cushing's syndrome."7.69Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome. ( Atkinson, RL; Cameron, DP; Cuneo, RC; Harper, J; Lee, W; Mitchell, K; Salkield, I; Ward, G, 1997)
"To develop criteria for interpreting results of the metyrapone test for the differential diagnosis of the adrenocorticotropin (ACTH)-dependent Cushing syndrome and to compare its diagnostic accuracy with that of the high-dose dexamethasone suppression test."7.69The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison. ( Avgerinos, PC; Cutler, GB; Nieman, LK; Oldfield, EH; Yanovski, JA, 1994)
"To analyse the clinical and biochemical effects of metyrapone in the treatment of Cushing's syndrome."7.68Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. ( Besser, GM; Grossman, AB; Howlett, TA; Perry, L; Rees, LH; Trainer, PJ; Verhelst, JA; Wass, JA, 1991)
"Cushing's syndrome due to bronchial carcinoid tumors that secrete adrenocorticotropin (ACTH) may be difficult to distinguish from pituitary Cushing's disease, since the responses to dexamethasone and metyrapone are sometimes similar."7.67Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. ( Abboud, C; Carey, RM; Carney, JA; Malchoff, CD; Orth, DN; Pairolero, PC, 1988)
"The adrenostatic effect of metyrapone (Metopiron) and aminoglutethimide (Orimeten) was assessed retrospectively in ten patients with ACTH-dependent Cushing's syndrome, four of them with the ectopic form."7.67[Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide]. ( Allolio, B; Jaursch-Hancke, C; Kaulen, D; Reincke, M; Winkelmann, W, 1987)
"Eighteen patients with Cushing's syndrome (16 pituitary-dependent Cushing's disease, 1 ectopic ACTH syndrome, 1 primary adrenal adenoma) were given a combination of aminoglutethimide and metyrapone, with the object of controlling cortisol overproduction using less toxic doses than would be required with each drug alone."7.65Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy. ( Burke, CW; Burley, DM; Child, DF; Fraser, TR; Rees, LH, 1976)
"To control hypercortisolism, the patient was treated with metyrapone."6.41Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone. ( Dokoupilová, M; Hána, V; Marek, J; Plavka, R, 2001)
"Osilodrostat is a new 11β-hydroxylase inhibitor with a mode of action analogous to Metyrapone."5.72Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients. ( Assié, G; Baron, S; Bertherat, J; Bessiene, L; Blanchet, B; Bonnet-Serrano, F; Bricaire, L; Groussin, L; Guibourdenche, J; Guignat, L; Laguillier-Morizot, C; Poirier, J; Vaczlavik, A, 2022)
"Metyrapone (MET) is an inhibitor of 11β-hydroxylase: retrospective studies reported a decrease of cortisol secretion in 50% of cases."5.48Metyrapone treatment in Cushing's syndrome: a real-life study. ( Albiger, N; Antonelli, G; Barbot, M; Boscaro, M; Ceccato, F; Plebani, M; Sabbadin, C; Scaroni, C; Watutantrige-Fernando, S; Zilio, M, 2018)
"The ketoconazole was shift to metyrapone but afterwards ketoconazole was added again."5.46A successful case of pregnancy in a woman with ACTH-independent Cushing's syndrome treated with ketoconazole and metyrapone. ( Michalak, R; Zieleniewski, W, 2017)
"Hypercortisolism was successfully controlled with metyrapone, which was started at 8 weeks of gestation."5.33Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. ( Blanco, C; Maqueda, E; Rodriguez, A; Rubio, JA, 2006)
"Treatment with metyrapone thus appears a good therapy for AIMAH, but its effectiveness has not, to our knowledge, been studied."5.31Rational, effective metyrapone treatment of ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH). ( Nomura, K; Obara, T; Omori, K; Omori, N; Takano, K, 2001)
"The hypercortisolism was controlled with metyrapone until elective delivery of the fetus by Caesarean section at 34 weeks gestation because of a decline in growth."5.29ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. ( Close, CF; Mann, MC; Taylor, KG; Watts, JF, 1993)
"Aldosterone excretion was high, normal, or low in each of the three types of Cushing's syndrome."5.26Deoxycorticosterone and aldosterone excretion in Cushing's syndrome. ( Cassar, J; Joplin, GF; Kelly, WF; Loizou, S; Mashiter, K, 1980)
"Cortisol was measured in serum from three patient groups: (1) patients receiving metyrapone (n = 112 samples from 10 patients); (2) control group of patients diagnosed with Cushing's syndrome currently receiving no treatment (n = 31); and (3) control group of patients with no adrenal pathology and not receiving medication known to interfere in cortisol immunoassay (n = 67)."5.15Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone. ( Brabant, G; Darby, D; Keevil, BG; Monaghan, PJ; Owen, LJ; Trainer, PJ, 2011)
"Fifteen patients with endogenous Cushing's syndrome were treated with metyrapone and/or amino-glutethimide."5.05Aminoglutethimide and metyrapone in the management of Cushing's syndrome. ( Adamson, U; Sjöberg, HE; Thorén, M, 1985)
"Inhibitors of steroid synthesis such as o,p'-DDD, aminoglutethimide, metyrapone, trilostane and ketoconazole are usually used for treatment of Cushing's syndrome in order to reduce the steroid production in the patients showing several complications, including severe hypertension and diabetes mellitus, and also an incomplete remission after the surgical treatment."4.79[Clinical usefulness of pharmacological treatment of Cushing's syndrome]. ( Nishikawa, T; Saito, J, 1994)
"Steroidogenesis inhibitors such as metyrapone (MTP) and osilodrostat (ODT) have a key role in the medical treatment of endogenous Cushing's Syndrome (ECS)."4.31LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing's Syndrome. ( Balakirouchenane, D; Bertherat, J; Blanchet, B; Bonnet-Serrano, F; Choi, M; Declèves, X; Groussin, L; Khoudour, N; Puszkiel, A; Vasseur, A; Vidal, M, 2023)
"Metyrapone and ketoconazole, frequently used steroidogenesis inhibitors for treatment of Cushing syndrome, can be associated with side effects and limited efficacy."3.91Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study. ( Creemers, SG; de Jong, FH; de Rijke, YB; Feelders, RA; Franssen, GJH; Hofland, LJ; van Koetsveld, PM, 2019)
"Steroidogenesis inhibitors, such as ketoconazole (KTZ) and metyrapone (MTP), are used to lower hypercortisolism in patients with Cushing's syndrome (CS)."3.85A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome. ( Aulinas, A; Glad, CA; Johannsson, G; Ragnarsson, O; Valassi, E; Webb, SM, 2017)
"We report a case of severe Cushing's syndrome developing into life-threatening acute respiratory distress syndrome with cryptococcus and cytomegalovirus co-infection soon after hypercortisolism treatment using metyrapone, an 11-beta-hydroxylase inhibitor."3.79[A case of acute respiratory distress syndrome caused by cryptococcus and cytomegalovirus co-infection after Cushing's syndrome treatment]. ( Goto, T; Sato, E; Takata, T; Tamura, K; Yanase, T, 2013)
"To evaluate the outcome of preoperative therapy with ketoconazole (KTZ) and/or metyrapone (MTP) in previously untreated patients with Cushing's syndrome (CS)."3.78A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome. ( Crespo, I; Gich, I; Rodríguez, J; Valassi, E; Webb, SM, 2012)
"Our objective was to assess the efficacy and safety of combination therapy with mitotane, metyrapone, and ketoconazole in severe ACTH-dependent Cushing's syndrome."3.77Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome. ( Baudin, E; Blanchard, A; Brailly-Tabard, S; Chanson, P; Droumaguet, C; Gautier, JF; Jublanc, C; Kamenický, P; Leboulleux, S; Salenave, S; Schlumberger, M; Young, J, 2011)
"Current guidance recommends titrating the dose of metyrapone against serum cortisol concentration, in patients under medical management of Cushing's syndrome."3.76Cortisol measurement in patients receiving metyrapone therapy. ( Halsall, DJ; Keevil, BG; Owen, LJ, 2010)
"We present a case of McCune-Albright syndrome revealed by a Cushing's syndrome treated by metyrapone."3.73[Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome]. ( Azzabi, O; Ben Ammar, B; Ben Hariz, M; Ben Mrad, N; Halioui-Louhaichi, S; Maherzi, A; Nefzi, L, 2005)
"Eighteen patients with Cushing's syndrome, five patients with hypocortisolemia, seven patients undergoing metyrapone testing, and 14 controls were studied."3.73Expression of the human glucocorticoid receptor splice variants alpha, beta, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism. ( Brinkmann, AO; de Jong, FH; Feelders, RA; Hagendorf, A; Koper, JW; Lamberts, SW, 2005)
"To develop criteria for interpreting results of the metyrapone test for the differential diagnosis of the adrenocorticotropin (ACTH)-dependent Cushing syndrome and to compare its diagnostic accuracy with that of the high-dose dexamethasone suppression test."3.69The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison. ( Avgerinos, PC; Cutler, GB; Nieman, LK; Oldfield, EH; Yanovski, JA, 1994)
"18 patients were studied on 21 occasions: three with Cushing's disease without metyrapone treatment prior to IPSS (M-), 11 with Cushing's disease with metyrapone pretreatment (M+), three with ectopic ACTH syndrome, and one with pseudo-Cushing's syndrome."3.69Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome. ( Atkinson, RL; Cameron, DP; Cuneo, RC; Harper, J; Lee, W; Mitchell, K; Salkield, I; Ward, G, 1997)
"We wished to develop optimal criteria for interpreting the single-dose overnight metyrapone test and to compare the diagnostic efficiency of the overnight and the standard 6-dose metyrapone tests for the differential diagnosis of ACTH-dependent Cushing's syndrome."3.69A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome. ( Avgerinos, PC; Cutler, GB; Nieman, LK; Oldfield, EH, 1996)
"The basal levels of 19-hydroxyandrostenedione in Cushing's disease were elevated (mean +/- SD; 323 +/- 193 pmol/l, n = 13), while those in Cushing's syndrome due to adrenal adenoma were low (92 +/- 24 pmol/l, n = 7), compared to those in normal subjects (117 +/- 33 pmol/l, n = 54)."3.68Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone. ( Miura, K; Morita, H; Mune, T; Murayama, M; Yamakita, N; Yasuda, K, 1993)
"To analyse the clinical and biochemical effects of metyrapone in the treatment of Cushing's syndrome."3.68Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. ( Besser, GM; Grossman, AB; Howlett, TA; Perry, L; Rees, LH; Trainer, PJ; Verhelst, JA; Wass, JA, 1991)
"The adrenostatic effect of metyrapone (Metopiron) and aminoglutethimide (Orimeten) was assessed retrospectively in ten patients with ACTH-dependent Cushing's syndrome, four of them with the ectopic form."3.67[Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide]. ( Allolio, B; Jaursch-Hancke, C; Kaulen, D; Reincke, M; Winkelmann, W, 1987)
"We describe thirty-one patients with Cushing's syndrome, with the object of evaluating the relative merit of the Dexamethasone suppression test, Metyrapone test and Corticotrophin Releasing Factor (CRF) test in classifying the syndrome."3.67[Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test]. ( Frey, H; Johannesen, O; Jørgensen, H; Norman, N, 1989)
"Cushing's syndrome due to bronchial carcinoid tumors that secrete adrenocorticotropin (ACTH) may be difficult to distinguish from pituitary Cushing's disease, since the responses to dexamethasone and metyrapone are sometimes similar."3.67Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor. ( Abboud, C; Carey, RM; Carney, JA; Malchoff, CD; Orth, DN; Pairolero, PC, 1988)
" In congenital adrenal hyperplasia, plasma ACTH concentrations mirror, together with 17-alpha-hydroxyprogesterone, the extent of ACTH suppression."3.67Plasma ACTH in diagnosis and control of adrenal disorders. ( Baumann, JB; Eberle, AN; Girard, J, 1986)
"The direct effects of etomidate, ketoconazole, miconazole and metyrapone were investigated on the secretion of cortisol and its precursors by dispersed cells from the adrenal cortex of a normal individual and four patients with Cushing's syndrome."3.67Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. ( Bons, EG; Bruining, HA; de Jong, FH; Lamberts, SW, 1987)
" Conservative treatment with metyrapone suppressed the Cushing syndrome."3.66[Successful conservative treatment of bronchial carcinoid with Cushing's syndrome due to ectopic ACTH production]. ( Euler, HH; Herrlinger, JD; Kirmse, L; Kleine, L; Löffler, H; Müller-Hermelink, HK, 1983)
"Subnormal plasma 11-deoxycortisol (compound S) responses to metyrapone were found in patients with adrenal insufficiency or with Cushing syndrome caused by adrenal tumors and in those receiving long-term glucocorticoid or diphenylhydantoin sodium therapy."3.65Single-dose metyrapone test: review of a four-year experience. ( Jubiz, W; Meikle, AW; Spiger, M; Tylor, FH; West, CD, 1975)
"Eighteen patients with Cushing's syndrome (16 pituitary-dependent Cushing's disease, 1 ectopic ACTH syndrome, 1 primary adrenal adenoma) were given a combination of aminoglutethimide and metyrapone, with the object of controlling cortisol overproduction using less toxic doses than would be required with each drug alone."3.65Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy. ( Burke, CW; Burley, DM; Child, DF; Fraser, TR; Rees, LH, 1976)
"However, hypercortisolism may persist or recur postoperatively; in other cases, the underlying tumor may not be resectable or its location may not be known."2.72Adrenally Directed Medical Therapies for Cushing Syndrome. ( Tritos, NA, 2021)
"Osilodrostat has been shown to be highly effective at maintaining normal urinary free cortisol in patients with CD."2.72Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide. ( Fleseriu, M; Han, AJ; Varlamov, EV, 2021)
"Severe hypercortisolism is characterized as a life-threatening endocrine condition in patients with Cushing syndrome, usually related to the concomitant onset of one or more comorbidities, requiring rapid normalization of cortisol concentrations and aggressive treatment of associated complications."2.72Medical therapy in severe hypercortisolism. ( Boguszewski, CL; Marques, JVO, 2021)
"Medical therapy to control hypercortisolism in adrenal Cushing's syndrome is currently not the first-line therapy."2.66What is the role of medical therapy in adrenal-dependent Cushing's syndrome? ( Braun, LT; Reincke, M, 2020)
"Treatment with metyrapone was started before pituitary surgery."2.66Pneumocystis pneumonia can complicate medical treatment of hypercortisolism even in outpatients with Cushing's disease. ( Carreau, A; Chabre, O; Cristante, J; Lepelley, M; Mallaret, M, 2020)
"The Metyrapone was given, the morning, in perfusion intravenous of saline serum over 2 hours."2.64[Changes in plasma level of corticotropin after intravenous injection of metyrapone. Value of this test in pituitary pathology]. ( Gabaude, B; Huguenin, A; Javalet, A; Murie, N, 1977)
"Bromocriptine therapy was discontinued after 16 weeks in the second patient due to the development of mental depression."2.64ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease. ( Kennedy, AL; Montgomery, DA; Sheridan, B, 1978)
"Pregnancy-induced Cushing's syndrome is exceptionally rare with fewer than ten cases reported in the world literature and none in Australia or New Zealand."2.48Pregnancy-induced Cushing's syndrome in recurrent pregnancies: case report and literature review. ( Achong, N; D'Emden, M; Fagermo, N; Mortimer, R, 2012)
"Cushing's syndrome is associated with serious morbidity and increased mortality."2.46Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole. ( de Herder, WW; Feelders, RA; Hofland, LJ, 2010)
"Active Cushing's syndrome is associated with insulin resistance induced by the high and prolonged circulating level of glucocorticoids."2.46Management of diabetes mellitus in Cushing's syndrome. ( Munir, A; Newell-Price, J, 2010)
"Cushing's syndrome is a complex endocrine condition with potential serious complications if untreated or inadequately treated."2.45Drugs in the medical treatment of Cushing's syndrome. ( Schteingart, DE, 2009)
"The most common cause of endogenous Cushing's disease in children older than 7 years is ACTH-dependent Cushing's disease (85%)."2.45[Cushing's syndrome: special issues]. ( Goñi Iriarte, MJ, 2009)
"Thus, we should treat Cushing's syndrome as soon as possible, since many complications, including cardiovascular diseases and infections, will soon occur when the definite diagnosis is delayed."2.44[Medical treatment for Cushing's syndrome]. ( Nishikawa, T; Omura, M; Saito, J, 2008)
"ACTH-dependent Cushing's syndrome is a heterogeneous disorder requiring a multidisciplinary and individualized approach to patient management."2.44Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. ( Bertagna, X; Bertherat, J; Biller, BM; Boscaro, M; Buchfelder, M; Colao, A; Grossman, AB; Hermus, AR; Hofland, LJ; Klibanski, A; Lacroix, A; Lindsay, JR; Melmed, S; Newell-Price, J; Nieman, LK; Petersenn, S; Sonino, N; Stalla, GK; Stewart, PM; Swearingen, B; Vance, ML; Wass, JA, 2008)
"Cushing's syndrome is an uncommon disorder, but one that often presents diagnostic challenges to the managing physician."2.42Dynamic tests in the diagnosis and differential diagnosis of Cushing's syndrome. ( Grossman, AB; Morris, DG, 2003)
"To control hypercortisolism, the patient was treated with metyrapone."2.41Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone. ( Dokoupilová, M; Hána, V; Marek, J; Plavka, R, 2001)
"Non-iatrogenic Cushing's syndrome has been associated primarily with three entities: pituitary-dependent processes due to pituitary adenomas or microadenomas causing adrenal hyperplasia; pituitary-independent primary adrenal causes, predominantly unilateral adenomas, rarely multiple adenomas or adrenal carcinoma; ectopic sources of adrenocorticotropic hormone (ACTH) production."2.37Primary adrenocortical nodular dysplasia, a distinct subtype of Cushing's syndrome. Case report and review of the literature. ( Cathey, WJ; Larsen, JL; Odell, WD, 1986)
"Treatment with metyrapone or o,p'-DDD can always induce a clinical remission but not a cure, and neurotransmitter therapy may be effective in a minority of cases."2.37Cushing's syndrome. ( Besser, GM; Howlett, TA; Rees, LH, 1985)
"Osilodrostat is a new 11β-hydroxylase inhibitor with a mode of action analogous to Metyrapone."1.72Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients. ( Assié, G; Baron, S; Bertherat, J; Bessiene, L; Blanchet, B; Bonnet-Serrano, F; Bricaire, L; Groussin, L; Guibourdenche, J; Guignat, L; Laguillier-Morizot, C; Poirier, J; Vaczlavik, A, 2022)
"Medical therapy can be used to treat Cushing syndrome and can result in improvement in the cardiovascular pathology."1.72Cushing syndrome as a failed cardiac screen in a patient with McCune-Albright syndrome: a case report. ( Al Zubeidi, H; Diaz-Thomas, A; Foster, C, 2022)
"Ruling out other causes, paraneoplastic hypercortisolism was diagnosed."1.51Hypokalaemic metabolic alkalosis, hypertension and diabetes: what is the link. ( Cathomas, R; Fehr, T; Kamber, N; Vögelin, M, 2019)
"Although endogenous Cushing's syndrome is rare in older people, it should always be considered among the differential diagnosis of behavioural disorders."1.48Behaviour disorder caused by Cushing's syndrome in an older person. ( Abbate, C; Belloni, G; Cesari, M; Chiodini, I; Damanti, S; Lucchi, T; Mandelli, C; Mari, D; Nestola, T, 2018)
"Metyrapone (MET) is an inhibitor of 11β-hydroxylase: retrospective studies reported a decrease of cortisol secretion in 50% of cases."1.48Metyrapone treatment in Cushing's syndrome: a real-life study. ( Albiger, N; Antonelli, G; Barbot, M; Boscaro, M; Ceccato, F; Plebani, M; Sabbadin, C; Scaroni, C; Watutantrige-Fernando, S; Zilio, M, 2018)
"Surgery is the definitive treatment of Cushing's syndrome (CS) but medications may also be used as a first-line therapy."1.48Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN. ( Bolanowski, M; Brue, T; Chabre, O; Chanson, P; Droste, M; Fajardo, C; Feelders, RA; Franz, H; Kastelan, D; Komerdus, I; Krsek, M; Maiter, D; Netea-Maier, R; Pfeifer, M; Reincke, M; Santos, A; Strasburger, CJ; Tabarin, A; Tóth, M; Trainer, PJ; Tsagarakis, S; Valassi, E; Wass, JAH; Webb, SM; Yaneva, M, 2018)
"The ketoconazole was shift to metyrapone but afterwards ketoconazole was added again."1.46A successful case of pregnancy in a woman with ACTH-independent Cushing's syndrome treated with ketoconazole and metyrapone. ( Michalak, R; Zieleniewski, W, 2017)
"The hypercortisolism is a rare endocrine disease characterized by an autonomous steroid secretion or excessive adrenal stimulation by ACTH."1.43[Indications and future perspectives in the pharmacological treatment of hypercortisolism]. ( Stigliano, A; Toscano, V, 2016)
"We report a case of McCune-Albright syndrome with CS treated with metyrapone for 30 months with prolonged remission after a 12-year follow-up."1.43[Recovery of Cushing syndrome revealing McCune-Albright syndrome]. ( Azzabi, O; Dridi, Y; Fetni, I; Halioui-Louhaichi, S; Maherzi, A; Selmi, I; Siala, N, 2016)
"Treatment with metyrapone led to a swift improvement of the patient's symptoms."1.42[Cushing's syndrome in a manic patient with a long-standing bipolar disorder: cause or coincidence?]. ( Bartel, M; de Witte, LD; Kleijweg, M; Smits, RB; Valk, GD; Vergeer, M; Vinkers, CH, 2015)
"The baby girl underwent medical treatment of Cushing's syndrome with metyrapone which was followed by a rapid recovery."1.42Neonatal McCune-Albright syndrome with systemic involvement: a case report. ( Dias, P; Gouveia, R; Lourenço, R; Oliveira, G; Sousa, AB, 2015)
"Cushing syndrome was diagnosed on the basis of a markedly elevated 24-hour urine free cortisol level and classic cushingoid features."1.35A patient with ectopic cortisol production derived from malignant testicular masses. ( Dluhy, RG; Jain, SH; Nosé, V; Sadow, PM, 2008)
"Hypercortisolism was successfully controlled with metyrapone, which was started at 8 weeks of gestation."1.33Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. ( Blanco, C; Maqueda, E; Rodriguez, A; Rubio, JA, 2006)
"Treatment with metyrapone thus appears a good therapy for AIMAH, but its effectiveness has not, to our knowledge, been studied."1.31Rational, effective metyrapone treatment of ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH). ( Nomura, K; Obara, T; Omori, K; Omori, N; Takano, K, 2001)
"The metyrapone test is a useful test in the assessment of outcome of pituitary surgery for Cushing's disease, with a sensitivity of 100% and a specificity of 75% for the early detection of patients at risk of a relapse."1.30Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease. ( de Herder, WW; de Jong, FH; Lamberts, SW; van Aken, MO; van der Lely, AJ, 1997)
"Ketoconazole treatment had success in to normalize the 24-hour UFC in all patients, except for the case of adrenal carcinoma."1.30[Cushing's syndrome: clinical study of fifteen cases]. ( Alvarez Barreiro, JA; Calvo Romero, JM; Diaz Pérez de Madrid, J; Morales Pérez, F, 1998)
"Ectopic Cushing's syndrome was suspected on the basis of high urinary free cortisol excretion (UFC) with a blunted circadian profile of serum cortisol and measurable plasma ACTH concentrations."1.29Misdiagnosis of Cushing's syndrome in a patient receiving rifampicin therapy for tuberculosis. ( Alì, A; Angeli, A; Boccuzzi, A; Borretta, G; Cesario, F; Magro, G; Reimondo, G; Terzolo, M, 1995)
"The hypercortisolism was controlled with metyrapone until elective delivery of the fetus by Caesarean section at 34 weeks gestation because of a decline in growth."1.29ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. ( Close, CF; Mann, MC; Taylor, KG; Watts, JF, 1993)
"Familial Cushing's syndrome is rare, and when it occurs, it is usually associated with primary micronodular dysplasia."1.29Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. ( Aron, DC; Engeland, WC; Findlay, JC; Sheeler, LR, 1993)
"Metyrapone was administered orally at a dosage of 65 mg/kg of body weight, every 12 hours."1.29Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds. ( Daley, CA; Powers, RD; Schick, RO; Zerbe, CA, 1993)
" A marked clinical and laboratory improvement was noted in two patients, in another some clinical and laboratory improvement was obtained only after bromocriptine dosage was increased to 15 mg/day."1.27Cushing's disease: clinical and laboratory response to bromocriptine therapy. ( Antunes, RC; de Pinho, MO; Francalanci, CC; Franco, S; Lima, MB, 1984)
"In vitro perifusion of the pituitary adenoma obtained by surgery revealed that o-CRF also stimulated ACTH and beta-EP release in a dose-responsive manner (10(-9)M 10(-5)M) and that dopamine suppressed their basal secretion."1.27Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease. ( Fujita, T; Hirata, Y; Nakashima, H; Tomita, M; Uchihashi, M, 1985)
"Metyrapone has been labelled with radioiodine selectively in the 4'-position of ring B."1.27Synthesis of radioiodinated metyrapone--a potential adrenal imaging agent. ( Robien, W; Zolle, I, 1983)
"The Cushing's syndrome was controlled medically, and when the patient deteriorated clinically she received treatment with a combination of BCNU, adriamycin, and ftorafur."1.26Successful therapy of an ACTH-producing gastric carcinoid APUD tumor: report of a case and review of the literature. ( Callen, PW; Churg, A; Friedman, MA; Harbour, J; Marcus, FS, 1980)
"The patient's hypercortisolism disappeared following removal of the chromophobe adenoma through transphenoidal hypophysectomy."1.26Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis. ( Liberman, B; Mesquita, CH; Tambascia, MA; Wajchenberg, BL, 1976)
"Metyrapone was used in the long-term management of 13 patients with pituitary-dependent bilateral adrenal hyperplasia (Cushing's disease)."1.26Metyrapone in long-term management of Cushing's disease. ( Besser, GM; Edwards, CR; Jeffcoate, WJ; Jones, AE; Rees, LH; Tomlin, S, 1977)
"The hypertension was alleviated by the administeration of dexamethasone in 2 of 3 patients with 17 alpha-hydroxylase deficiency."1.26Hypertension induced by adrenocortical dysfunction--hypertension in 17 alpha-hydroxylase deficiency and metopirone-induced hypertension. ( Kato, E; Kitajima, W; Kondo, K; Konishi, K; Matsuki, S; Nakamura, R; Ohguro, T; Oka, M; Ozawa, Y; Saito, I; Saruta, T; Yamagami, K, 1978)
" Long-term administration of cyproheptadine appeared to normalize excessive adrenocorticotropic hormone (ACTH) production by reducing the frequency and the peak levels of episodic secretion of ACTH."1.26Cyproheptadine in the control of Cushing's disease. ( Gann, DS; Hsu, TH; Russell, RP; Tsan, KW, 1981)
"Therefore, hypercortisolism probably selectively interferes with the regulation of PRL secretion at a suprahypophyseal level."1.26Regulation of prolactin secretion in patients with Cushing's disease. A comparative study on the effects of dexamethasone, lysine vasopressin and ACTH on prolactin secretion by the rat pituitary gland in vitro. ( de Quijada, M; Lamberts, SW; Visser, TJ, 1981)
"Aldosterone excretion was high, normal, or low in each of the three types of Cushing's syndrome."1.26Deoxycorticosterone and aldosterone excretion in Cushing's syndrome. ( Cassar, J; Joplin, GF; Kelly, WF; Loizou, S; Mashiter, K, 1980)
"Six nonadrenalectomized patients with pituitary tumors showed similar abnormalities of ACTH regulation."1.25Studies of ACTH secretion control in 116 cases of Cushing's syndrome. ( Binoux, M; Girard, F; Gourmelen, M; Luton, JP; Raux, MC, 1975)
"Treatment with metyrapone decreased her cortisol production and produced clinical remission of Cushing's syndrome."1.25The immunological hazard of Cushing's syndrome. ( Britton, S; Sjoberg, HE; Thorén, M, 1975)

Research

Studies (389)

TimeframeStudies, this research(%)All Research%
pre-1990258 (66.32)18.7374
1990's51 (13.11)18.2507
2000's29 (7.46)29.6817
2010's37 (9.51)24.3611
2020's14 (3.60)2.80

Authors

AuthorsStudies
Emmerich, J1
Hu, Q1
Hanke, N1
Hartmann, RW1
Vega-Beyhart, A1
Laguna-Moreno, J1
Díaz-Catalán, D1
Boswell, L1
Mora, M1
Halperin, I1
Casals, G1
Hanzu, FA1
Bonnet-Serrano, F2
Poirier, J1
Vaczlavik, A1
Laguillier-Morizot, C1
Blanchet, B2
Baron, S1
Guignat, L1
Bessiene, L1
Bricaire, L2
Groussin, L2
Assié, G1
Guibourdenche, J1
Bertherat, J3
Pivonello, R1
Simeoli, C1
Di Paola, N1
Colao, A2
Foster, C1
Al Zubeidi, H1
Diaz-Thomas, A1
Lugat, A1
Lasolle, H1
François, M1
Benhenda, N1
Cornu, E1
Cristante, J2
Gitton, A1
Hadoux, J1
Kerlan, V1
Le Bras, M1
Mezzaroba, V1
Puerto, M1
Storey, C1
Ouzounian, S1
Donadille, B1
Raverot, G1
Drui, D1
Haissaguerre, M2
Balakirouchenane, D1
Vasseur, A1
Choi, M1
Khoudour, N1
Puszkiel, A1
Vidal, M1
Declèves, X1
Braun, LT1
Reincke, M5
Newell-Price, J6
Nieman, LK5
Tabarin, A5
Beretta, F1
Dassie, F1
Parolin, M1
Boscari, F1
Barbot, M2
Busetto, L1
Mioni, R1
De Carlo, E1
Scaroni, C2
Fallo, F1
Vettor, R1
Maffei, P1
Tritos, NA2
Lepelley, M1
Mallaret, M1
Carreau, A1
Chabre, O2
Marques, JVO1
Boguszewski, CL1
Castinetti, F1
Varlamov, EV1
Han, AJ1
Fleseriu, M1
Valassi, E3
Aulinas, A1
Glad, CA1
Johannsson, G1
Ragnarsson, O1
Webb, SM4
Humayun, MA1
Hart, T1
Richardson, T1
Claps, M1
Cerri, S1
Grisanti, S1
Lazzari, B1
Ferrari, V1
Roca, E1
Perotti, P1
Terzolo, M2
Sigala, S1
Berruti, A1
Franz, H1
Brue, T1
Feelders, RA4
Netea-Maier, R1
Tsagarakis, S1
Yaneva, M1
Droste, M1
Komerdus, I1
Maiter, D1
Kastelan, D1
Chanson, P3
Pfeifer, M1
Strasburger, CJ1
Tóth, M1
Krsek, M1
Fajardo, C1
Bolanowski, M1
Santos, A1
Trainer, PJ4
Wass, JAH1
Rouland, A1
Nguyen, A1
Fourmont, C1
Lapray, M1
Vergès, B1
Petit, JM1
Bouillet, B1
Damanti, S1
Abbate, C1
Chiodini, I1
Cesari, M1
Nestola, T1
Belloni, G1
Mandelli, C1
Mari, D1
Lucchi, T1
Ceccato, F1
Zilio, M1
Albiger, N1
Antonelli, G1
Plebani, M1
Watutantrige-Fernando, S1
Sabbadin, C1
Boscaro, M3
Ollivier, M1
Ferriere, A1
Vögelin, M1
Cathomas, R1
Kamber, N1
Fehr, T1
Creemers, SG1
de Jong, FH6
Franssen, GJH1
de Rijke, YB1
van Koetsveld, PM1
Hofland, LJ3
Goto, T1
Takata, T1
Sato, E1
Tamura, K1
Yanase, T2
Ozawa, W1
Sato, K1
Miyakoshi, T1
Nishio, S1
Yamazaki, M1
Suzuki, S2
Komatsu, M1
Corcuff, JB1
Young, J2
Masquefa-Giraud, P1
Baudin, E2
Daniel, E2
Newell-Price, JD1
Lourenço, R1
Dias, P1
Gouveia, R1
Sousa, AB1
Oliveira, G1
Aylwin, S1
Mustafa, O1
Ball, S1
Munir, A2
Boelaert, K1
Chortis, V1
Cuthbertson, DJ1
Daousi, C1
Rajeev, SP1
Davis, J1
Cheer, K1
Drake, W1
Gunganah, K1
Grossman, A2
Gurnell, M2
Powlson, AS1
Karavitaki, N1
Huguet, I1
Kearney, T1
Mohit, K1
Meeran, K1
Hill, N1
Rees, A1
Lansdown, AJ1
Minder, AE1
de Witte, LD1
Smits, RB1
Bartel, M1
Kleijweg, M1
Valk, GD1
Vinkers, CH1
Vergeer, M1
Halioui-Louhaichi, S2
Dridi, Y1
Azzabi, O2
Selmi, I1
Fetni, I1
Siala, N1
Maherzi, A2
Alexandraki, KI1
Grossman, AB5
Stigliano, A2
Toscano, V2
Cerquetti, L1
Zieleniewski, W1
Michalak, R1
Jain, SH1
Sadow, PM1
Nosé, V1
Dluhy, RG1
Cohade, C1
Broussaud, S1
Louiset, E1
Bennet, A1
Huyghe, E1
Caron, P1
Goñi Iriarte, MJ1
Hotham, NJ1
Ilett, KF1
Hackett, LP1
Morton, MR1
Muller, P1
Hague, WM1
Mangan, JK1
Russell, JE1
Vong, CH1
Forest, M1
Nicolino, M1
Schteingart, DE6
Akaza, I1
Yoshimoto, T1
Tsuchiya, K1
Hirata, Y3
de Herder, WW2
Owen, LJ2
Halsall, DJ2
Keevil, BG2
Kamenický, P1
Droumaguet, C1
Salenave, S1
Blanchard, A1
Jublanc, C1
Gautier, JF2
Brailly-Tabard, S1
Leboulleux, S1
Schlumberger, M1
Monaghan, PJ1
Brabant, G1
Darby, D1
Schiemer, R1
Latibeaudiere, M1
Close, C1
Fox, R1
Yoshida, M1
Umeda, H1
Iwama, S1
Nakayama, S1
Miyata, M1
Ogawa, K1
Maeda, H1
Oiso, Y2
Achong, N1
D'Emden, M1
Fagermo, N1
Mortimer, R1
Carroll, BJ1
Iranmanesh, A1
Keenan, DM1
Cassidy, F1
Wilson, WH1
Veldhuis, JD1
Biller, BM2
Crespo, I1
Gich, I1
Rodríguez, J1
Lim, WH1
Torpy, DJ1
Jeffries, WS1
Shaw, JA1
Pearson, DW1
Krukowski, ZH1
Fisher, PM1
Bevan, JS2
Lubin, V1
Antoine, JM1
Beressi, JP1
Vexiau, P1
DE MARTINIS, C1
PUPITA, F1
WEBER, J1
DITZEL, J2
DANIELS, H1
SCHOPMAN, W1
GOTH, E1
POLLAK, L1
KOSEKI, A1
SHINOHARA, M1
MURAYAMA, K1
TAKANO, J1
TSUNOKAKE, H1
MITSUBE, K1
PARIS, J1
FAGLIA, G1
D ALONZO, R1
NORBIATO, G1
ORTHMANN, G1
LIUZZI, A1
FERRARI, E1
PIOTTI, LE1
BOSCHERINI, B1
FISCHETTI, M1
MOLINATTI, GM2
CAMANNI, F1
MASSARA, F2
MAGGIOLO, J1
CASTIGLIONI, CA1
OLIVIERI, E1
LAMBERG, BA1
LENTLE, BC1
THOMAS, JP1
DANOWSKI, TS2
BONESSI, JV1
SABEH, G1
SUTTON, RD1
WEBSTER, MW1
SARVER, ME1
WILLIAMSON, CI1
BAKER, OA1
BEETHAM, WP1
IORI, E1
SOLA, OH1
VILANOVA, D1
HOFFMAN, C1
KOSANIK, M1
WAINER, AC1
SOBOTA, JT1
REED, RJ1
SUMMERS, VK1
SHEEHAN, HL1
HIPKIN, LJ1
DAVIS, JC1
TAMM, J1
KUMAGAI, H1
JANCHES, M1
GOLDBERG, V1
JAIMOVICH, L1
CATOGGIO, P1
DELABALZE, FA1
SULLIVAN, WA1
HYDROVITZ, JD1
ROSOMOFF, H1
MCCULLAGH, EP1
FELDSTEIN, MA1
TWEED, DC1
DOHN, DF1
ROBEL, P1
Morris, DG1
Kawashima, T1
Oda, M1
Kuno, T1
Ueki, H1
Yamada, S2
Hisatomi, A1
Nefzi, L1
Ben Hariz, M1
Ben Mrad, N1
Ben Ammar, B1
Hagendorf, A1
Koper, JW1
Brinkmann, AO1
Lamberts, SW6
Mizuki, K1
Nawata, H1
Greening, JE1
Brain, CE1
Perry, LA1
Mushtaq, I1
Sales Marques, J1
Savage, MO1
Blanco, C1
Maqueda, E1
Rubio, JA1
Rodriguez, A1
Nishikawa, T2
Saito, J2
Omura, M1
Dang, CN1
Trainer, P2
Myhill, PC1
Sillars, BA1
Starkstein, S1
Annus, T1
Yeap, BB1
Stewart, PM1
Melmed, S1
Bertagna, X1
Buchfelder, M1
Hermus, AR2
Klibanski, A1
Lacroix, A1
Lindsay, JR1
Petersenn, S1
Sonino, N1
Stalla, GK1
Swearingen, B1
Vance, ML1
Wass, JA3
Gillis, D1
Rösler, A1
Hannon, TS1
Koplewitz, BZ1
Hirsch, HJ1
Hartog, M2
Joplin, GF6
Fotherby, K1
Mattingly, D1
Fraser, TR2
Streeten, DH1
Anderson, GH1
Dalakos, TG1
Seeley, D1
Mallov, JS1
Eusebio, R1
Sunderlin, FS1
Badawy, SZ1
King, RB1
Gogel, EL1
Salber, PR1
Tyrrell, JB1
Rosenblum, ML1
Findling, JW2
Howanitz, PJ1
Howanitz, JH1
de Pinho, MO1
Antunes, RC1
Lima, MB1
Francalanci, CC1
Franco, S1
Glaser, B1
Kahana, L1
Elias, V1
Sheinfeld, M1
Dal Bo Zanon, R1
Fornasiero, L1
Ruffato, G1
Luzzato, G1
Fabris, F1
Girolami, A1
Carey, RM3
Tsao, HS1
McKenzie, AK1
Marcus, FS1
Friedman, MA1
Callen, PW1
Churg, A1
Harbour, J1
de Quijada, M1
Visser, TJ1
Liddle, GW5
Hsu, TH1
Gann, DS1
Tsan, KW2
Russell, RP1
Bertagna, C1
Orth, DN11
Beardwell, CG3
Adamson, AR1
Shalet, SM2
Bergstrand, CG1
Nilsson, KO1
Wetterberg, L1
Hiramatsu, R1
Shimada, T1
Sato, T2
Nomura, K2
Demura, H6
Imaki, T1
Miyagawa, M1
Ono, M1
Yano, T1
Shizume, K2
Bouallouche, A1
Vermeulen, C1
Brerault, JL1
Fiet, J1
Julien, R1
Guillevin, L1
Abou-Samra, AB1
Fevre-Montange, M1
Pugeat, M1
Dechaud, H1
Chalendar, D1
Estour, B1
Tourniaire, J1
Jenkins, RM1
Page, MM1
Sindler, BH1
Griffing, GT1
Melby, JC3
Herrlinger, JD1
Euler, HH1
Kleine, L1
Kirmse, L1
Müller-Hermelink, HK1
Löffler, H1
Robien, W1
Zolle, I1
Krieger, DT2
Gormley, MJ1
Hadden, DR1
Kennedy, TL1
Montgomery, DA2
Murnaghan, GA1
Sheridan, B2
Zgliczyński, S1
Bricaire, H3
Luton, JP5
Cassar, J2
Loizou, S2
Kelly, WF2
Mashiter, K2
Borretta, G1
Alì, A1
Cesario, F1
Magro, G1
Boccuzzi, A1
Reimondo, G1
Angeli, A2
Miller, JW1
Crapo, L1
Freeman, DA1
Miura, K7
Myers, NC1
Bruyette, DS1
Minamori, Y1
Yasuda, K2
Murayama, M2
Morita, H2
Yamakita, N2
Engelhardt, D2
Avgerinos, PC2
Yanovski, JA1
Oldfield, EH2
Cutler, GB2
Weber, MM1
Gaitan, D1
Loosen, PT1
Gibson, S1
Crosby, SR1
Stewart, MF1
Jennings, AM1
McCall, E1
White, A2
Kodama, C1
Nakada, T1
Sasagawa, I1
Ishigooka, M1
Yamaguchi, T1
Suzuki, H1
Watanobe, H2
Tamura, T1
Close, CF1
Mann, MC1
Watts, JF1
Taylor, KG1
Raux-Demay, MC1
Girard, F3
Suda, T3
Tozawa, F1
Dobashi, I1
Horiba, N2
Ohmori, N1
Yamakado, M1
Yamada, M1
Findlay, JC1
Sheeler, LR1
Engeland, WC1
Aron, DC1
Mune, T1
Daley, CA1
Zerbe, CA1
Schick, RO1
Powers, RD1
Tanaka, K2
Toriumi, M1
Itoh, S1
Ogino, Y1
Cuneo, RC1
Lee, W1
Harper, J1
Mitchell, K1
Ward, G1
Atkinson, RL1
Salkield, I1
Cameron, DP1
Rossi, MA2
Chervin, RA1
Bruno, OD2
van Aken, MO1
van der Lely, AJ1
Jeffcoate, W1
Tamura, H1
Sugihara, H1
Minami, S1
Emoto, N1
Shibasaki, T1
Shuto, Y1
Shimizu, K1
Gomi, Y1
Sasano, H1
Wakabayashi, I1
Calvo Romero, JM1
Morales Pérez, F1
Alvarez Barreiro, JA1
Diaz Pérez de Madrid, J1
Besser, M1
Hayashi, Y1
Takeda, Y1
Kaneko, K1
Koyama, H1
Aiba, M1
Ikeda, U1
Shimada, K1
Kasperlik-Zaluska, AA1
Szczupacka, I1
Leszczynska-Bystrzanowska, J1
Drus-Przybyszewska, G1
Puig, J1
Wägner, A1
Caballero, A1
Rodríguez-Espinosa, J1
Ray, DW1
Talbot, A1
Abraham, P1
Thody, AJ1
Hána, V1
Dokoupilová, M1
Marek, J2
Plavka, R1
Shimizu, C1
Yamane, Y1
Ishizuka, T1
Kijima, H1
Takano, K2
Takano, A1
Kubo, M1
Koike, T1
Omori, N1
Omori, K1
Obara, T2
Sarac, MS1
Zieske, AW1
Lindberg, I1
Inagaki, M1
Akizuki, N1
Kugaya, A1
Fujii, H1
Akechi, T1
Uchitomi, Y1
Besser, GM5
Jeffcoate, WJ2
Klijn, JG1
Birkenhäger, JC3
Matys, Z1
Gregorová, I1
Schnall, AM1
Brodkey, JS1
Kaufman, B1
Pearson, OH1
Raux, MC1
Binoux, M2
Gourmelen, M1
Pelkonen, R1
Spence, RW1
Burns-Cox, CJ1
Hashimoto, K4
Sakamoto, N1
Yamamoto, H1
Matsukura, S3
Imura, H2
Okada, S1
Child, DF1
Burke, CW2
Burley, DM1
Rees, LH6
Groos, G1
Tharandt, L1
Benker, G1
Zäh, W1
Hackenberg, K2
Reinwein, D1
Upton, GV1
Seldenrath, HJ1
Tashjian, AH1
Liberman, B1
Wajchenberg, BL1
Tambascia, MA1
Mesquita, CH1
Iwai, K1
Honda, H1
Sugawara, M1
Hagen, GA1
Ganguly, A1
Meikle, AW4
Tyler, FH5
West, CD7
Murie, N1
Gabaude, B1
Javalet, A1
Huguenin, A1
Tomlin, S1
Jones, AE2
Edwards, CR1
Delaney, JP1
Solomkin, JS1
Jacobson, ME1
Doe, RP1
Dolman, LI1
Saruta, T1
Nakamura, R1
Saito, I1
Kondo, K1
Ohguro, T1
Yamagami, K1
Kitajima, W1
Oka, M1
Konishi, K1
Ozawa, Y1
Kato, E1
Matsuki, S1
Kennedy, AL1
Ross, WM1
Evered, DC1
Hunter, P1
Benaim, M1
Cook, D1
Hall, R2
Barnes, AJ1
White, M1
Welbourn, RB1
Fehm, HL2
Voigt, KH2
Koelmeyer, TD1
Woods, WP1
Bartley, PC1
Barbarino, A1
de Marinis, L1
Liberale, I1
Menini, E1
Prinz, RA1
Brooks, MH1
Lawrence, AM1
Paloyan, E1
McElduff, A1
Clifton-Bligh, P1
Posen, S1
Wiedemann, E2
Saito, T2
Linfoot, JA2
Li, CH2
Kammer, H1
Barter, M1
deAsis, DN1
Samaan, NA2
Rorstad, O1
Urtasun, R1
Watanabe, M1
Nakagawa, K1
Keimatsu, M1
Ito, Y1
Kunita, H1
Spiger, M1
Jubiz, W3
Tylor, FH1
Britton, S1
Thorén, M2
Sjoberg, HE2
Tucci, JR3
Loewenstein, JE1
Green, JR1
van't Hoff, W1
Hashimoto, H1
Miyoshi, M1
Yozai, S1
Ogawa, N2
Takahara, J3
Starkova, NT1
Dimopoulos, MA1
Fernandez, JF1
Holoye, PY1
Vassilopoulou-Sellin, R1
Menéndez Torre, EL1
López Carballo, MT1
Rodríguez Erdozain, R1
Urbieta Echezarreta, M1
Lafita Tejedor, J1
Forga Llenas, L1
Snow, K1
Jiang, NS1
Kao, PC1
Scheithauer, BW1
Starkman, MN1
Schork, MA1
Kato, S1
Masunaga, R1
Kawabe, T1
Nagasaka, A1
Miyamoto, T1
Itoh, M1
Nakai, A1
Iwase, K1
Tsujimura, T1
Ohtani, S1
Noritake, M1
Morimoto, K1
Kosano, H1
Nemoto, Y1
Kugai, N1
Takao, M1
Murai, M1
Tamai, S1
Nagata, N1
Shapiro, MS1
Shenkman, L1
Verhelst, JA1
Howlett, TA4
Perry, L1
Nomura, H1
Azuma, S1
Soma, R1
Fujii, S1
Koni, I1
Nakabayashi, H1
Tofuku, Y1
Takeda, R1
Kato, Y1
Murphy, BE1
Atkinson, AB1
Burguera, B1
Muruais, C1
Peñalva, A1
Dieguez, C1
Casanueva, FF1
Totani, Y1
Niinomi, M1
Takatsuki, K1
Tomita, A1
Limone, P1
Maccario, M1
Vigliani, R1
Isaia, G1
Blunt, SB2
Sandler, LM1
Burrin, JM3
Littley, MD1
Ahmed, SR1
Sutton, ML1
Malchoff, CD2
Rosa, J1
DeBold, CR1
Kozol, RA1
Ramsby, GR1
Page, DL1
Malchoff, DM1
Raff, H1
Johannesen, O1
Jørgensen, H1
Frey, H1
Norman, N2
Plowman, PN1
Takebe, K4
Pirmohamed, M1
Chatterjee, VK1
Allison, DJ1
Makino, S1
Sugiyama, M1
Hirasawa, R1
Takao, T1
Ota, Z2
Saegusa, M1
Ohashi, T2
Omori, H2
Allolio, B1
Jaursch-Hancke, C1
Kaulen, D1
Winkelmann, W3
Abboud, C1
Carney, JA2
Pairolero, PC1
Fuhrman, SA1
Nakashima, H1
Uchihashi, M1
Tomita, M1
Fujita, T1
Contreras, LN1
Gómez, RM1
Galparsoro, G1
Cazado, E1
Kral, M1
Leber, B1
Arias, D1
Wand, GS1
Ney, RL2
Tomori, N1
Yajima, F1
Sumitomo, T1
Nakagami, Y1
Ushiyama, T1
Kawagishi, T1
Hirai, Y1
Tsutsui, M1
Kamata, Y1
Kuo, CY1
Carpenter, PC2
Dickstein, G1
Lahav, M1
Shen-Orr, Z1
Edoute, Y1
Barzilai, D1
Harris, PL1
Larsen, JL1
Cathey, WJ1
Odell, WD1
Donckier, J1
Ramsay, ID1
Girard, J1
Eberle, AN1
Baumann, JB1
Kawada, Y1
Murakami, K1
Hattori, T1
Suemaru, S1
Kageyama, J1
Hayata, S1
Bons, EG1
Bruining, HA1
Peterson, ME1
Drucker, WD1
Turnell, DC1
Cooper, JD1
Green, B1
Hughes, G1
Wright, DJ1
Cagliero, E1
Lorenzi, M1
Lloyd, RV1
Akil, H1
Chandler, WF1
Ibarra-Perez, G1
Rosen, SG1
Ogletree, R1
Lewis, JG1
Yeo, KH1
Elder, PA1
Grant, CS1
van Heerden, JA1
Adamson, U1
Kramlinger, KG1
Peterson, GC1
Watson, PK1
Leonard, LL1
Connell, JM1
Cordiner, J1
Davies, DL1
Fraser, R1
Frier, BM1
McPherson, SG1
Hartmann, WH1
Pratt, JH1
Sawin, CT1
Milcu, SM1
Nicolescu-Catargi, A1
Martin, MM1
Hamman, BL1
Hammond, W1
Wright, L1
Davis, WW1
Acker, J1
Bartter, FC1
Brooks, RV1
Jeffcoate, SL1
London, DR1
Prunty, FT1
Smith, PM1
Vermeulen, A1
Verdonck, G1
Van der Straeten, M1
Daneels, R1
Smilo, RP2
Earll, JM1
Forsham, PH2
Sasaki, C2
Katsushima, I1
Ohtomo, T1
Sato, S1
Torikai, T2
Sasano, N1
Fehér, T1
Steel, K1
Baerg, RD1
Adams, DO1
Werk, EE2
Thrasher, K1
Choi, Y2
Sholiton, LJ2
Espiner, EA3
Jagger, PI3
Lauler, DP3
Wynn, V2
Landon, J2
James, VH2
Peart, WS1
Giusti, G1
Toccafondi, R1
Tarquini, B1
Bacchus, H1
Greenwood, FC1
Abate, G1
Bernardi, P1
Allegro, G1
Isidori, A2
Frajese, G1
Dondero, F2
Strott, CA1
Nugent, CA1
Coll, R1
Horner, I1
Kraiem, Z1
Gafni, J1
Livanou, T1
Ferriman, D1
Corns, M1
Ruedi, B1
Felber, JP1
Aubert, M1
Sturm, A1
Thorn, GW1
Donahower, GF1
Schumacher, OP1
Hazard, JB1
Berson, SA2
Yalow, RS2
Weber, A1
Gossmann, HH1
Jones, JE2
Shane, SR1
Gilbert, E1
Flink, EB1
Few, JD1
Minozzi, M1
Faggiano, M1
Salerno, M1
Lombardi, G1
Nunziata, V1
Sako, T1
Sparks, LL1
Pavlatos, FC1
Leprat, J1
Kubo, N1
Litta-Modignani, R1
Badoni, M1
Abe, K2
Nicholson, WE1
Island, DP1
Bethge, H2
Bayer, JM2
Rayyis, SS2
Bethune, JE2
Bonanni, G1
Miura, S1
French, FS1
Macfie, JA1
Baggett, B1
Williams, TF1
Van Wyk, JJ1
Hasui, K1
Pennington, LF1
Kreisberg, RA2
Hershman, JM2
Weiss, ER1
Nelson, DH2
Brun, J1
Revol, A2
Queneau, P1
Sachs, BA1
Becker, N1
Bloomberg, AE1
Grunwald, RP1
Ofuji, T2
Iino, M1
Demura, E1
Crystal, RG1
Rose, LI1
Favus, MJ1
Shuster, S1
Laurencet, FL1
Jenny, M1
Muller, AF1
Morimoto, Y1
Hiwada, K1
Nanahoshi, M1
Yano, S1
Kumagai, A1
Yamamura, Y1
Koto, K1
Uda, H1
Okano, K1
Yamane, G1
Negro, F1
Ichikawa, Y1
Harada, G2
Yuji, S1
Nakajima, T2
Watanabe, A1
Shimizu, N1
Kato, T1
Vingerhoeds, AC1
Thijssen, JH1
Schwarz, F1
Nishida, S2
Gourmelen-Combourieu, M1
Pham-Huu-Trung, MT1
Matsuyama, H1
Ruhmann-Wennhold, A1
Silvestrini, F1
D'Alonzo, R1
Siegal, AM1
Owen, WC1
Sakakura, M1
Mashimo, K1
Kracht, J1
Donald, RA1
Beaven, DW1
Brown, RD1
Van Loon, GR1
Meng, W1
Meng, S1
Raith, L1
Mendilaharzu, H1
Gregory, T1
Gardner, LI1
Boccuzzi, G1
Frairia, R1
Bisbocci, D1
Reck, R1
Pfeiffer, EF1
Lagerquist, LG1
Hunter, PR1
Ross, W1
Cook, DB1
Steinbeck, AW1
Theile, HM1
Wilson, LD1
Oldham, SB1
Harding, BW1
Drafta, D1
Ciocîrdia, C1
Stroe, E1
Tache, A1
Cristoveanu, A1
Bunea, M1
Koller, F1
Thorens, B1
Riondel, AM2
Scholer, D1
Kenny, FM2
Santelices, R1
Poulsen, JE1
Asfeldt, VH1
Shahmanesh, M1
Crook, D1
Sizonenko, PC1
Doret, AM1
Paunier, L1
Chen, R1
Drash, AL1
Conn, JW1
Lieberman, LM1
Beierwaltes, WH1
Croughs, RJ2
Docter, R1
Graham, NA1
Seal, US1
Jacobs, HS1
Nabarro, JD1
Kleinfelder, H1
Guinet, P1
Mornex, R1
Bertrand, J1
Veyrat, A1
Dorsit, G1
Katsuki, S1
Tada, T1
Blunck, W1
Bierich, JR1
Hutchings, MP1
Loridan, L1
Senior, B1
Horster, FA1
Heni, F1
Cope, CL1
Dennis, PM1
Pearson, J1
Katz, J1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Metabolic, Pressor and Neuropsychological Effects of Metyrapone Treatment in Patients With Hypercortisolism[NCT05255900]20 participants (Anticipated)Observational2022-04-28Recruiting
Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma[NCT03145285]Phase 210 participants (Anticipated)Interventional2017-04-18Active, not recruiting
Treatment of Pituitary Cushing Disease With a Selective CDK Inhibitor, R-roscovitine[NCT02160730]Phase 24 participants (Actual)Interventional2014-05-31Terminated (stopped due to NIH grant ended.)
An Open-label Study of the Efficacy and Safety of CORLUX (Mifepristone) in the Treatment of the Signs and Symptoms of Endogenous Cushing's Syndrome[NCT00569582]Phase 350 participants (Actual)Interventional2007-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants That Experience Changes in Clinical Signs of Hypercortisolemia

The number of participants that achieved a urinary free cortisol level above the upper limit of the normal range but reduced by ≥50% from baseline at week 4. (NCT02160730)
Timeframe: Baseline, Week 4

InterventionParticipants (Count of Participants)
R-roscovitine2

Number of Participants That Have a Visible Change in Tumor Size

A visible change in tumor size as determined by the investigator after reviewing MRI reports between baseline and 4 weeks of treatment. (NCT02160730)
Timeframe: Baseline, 4 weeks

InterventionParticipants (Count of Participants)
R-roscovitine0

Number of Participants With a Normalized 24 Hour Urinary Free Cortisol After 4 Weeks

"To evaluate the efficacy of R-roscovitine 400 mg oral administration twice daily for 4 days every week for total of 4 weeks on normalizing 24 hour urinary free cortisol (24 h UFC) levels in CD patients. Normalizing is defined as having urine free cortisol levels within the normal range for that lab value." (NCT02160730)
Timeframe: Baseline, 4 weeks

InterventionParticipants (Count of Participants)
R-roscovitine0

Number of Participants With Adverse Events

The number of participants that experience an adverse event between baseline and study end likely related to study drug as a measure of safety and tolerability. (NCT02160730)
Timeframe: Baseline, 4 weeks

InterventionParticipants (Count of Participants)
R-roscovitine2

Change in Clinical Symptoms

Change in typical Cushing's syndrome clinical signs and symptoms defined by mean weight at baseline and 4 weeks. (NCT02160730)
Timeframe: Baseline, 4 weeks

Interventionlbs (Mean)
Baseline4 Weeks
R-roscovitine217217.4

Change in Diastolic Blood Pressure

Mean diastolic blood pressure between baseline and 4 weeks. (NCT02160730)
Timeframe: Baseline, 4 weeks

InterventionmmHg (Mean)
Baseline4 Weeks
R-roscovitine76.571

Change in Mean HbA1c Levels Between Baseline and 4 Weeks

HbA1c levels are measured at baseline and at study end, these are averaged across all subjects. (NCT02160730)
Timeframe: Baseline, 4 Weeks

InterventionPercentage (Mean)
BaselineStudy End-4 weeks
R-roscovitine6.97

Change in Systolic Blood Pressure

Mean change in systolic blood pressure between baseline and 4 weeks. (NCT02160730)
Timeframe: Baseline, 4 weeks

InterventionmmHg (Mean)
Baseline4 weeks
R-roscovitine150.3128.3

Changes in Serum Cortisol Between Baseline and 4 Weeks

Mean serum cortisol values at baseline and 4 weeks (NCT02160730)
Timeframe: Baseline, 4 weeks

Interventionmg/dL (Mean)
Baseline4 Weeks
R-roscovitine25.627.1

Fasting Glucose at Baseline and 4 Weeks

Mean change between baseline and week 4 of fasting blood glucose levels. (NCT02160730)
Timeframe: Baseline, 4 Weeks

Interventiong/dL (Mean)
Baseline4 weeks
R-roscovitine121.4104.3

Plasma ACTH at Baseline and 4 Weeks

Mean change in Plasma ACTH between baseline and 4 weeks. (NCT02160730)
Timeframe: Baseline, 4 weeks

Interventionpg/mL (Mean)
Baseline4 weeks
R-roscovitine79.379.9

Decrease in Diastolic Blood Pressure.

Responder is defined as subject with a decrease greater than or equal to 5mm Hg in diastolic blood pressure from baseline to week 24 or last visit. (NCT00569582)
Timeframe: Baseline to Week 24

Interventionparticipants (Number)
Mifepristone8

Improvement in Diabetes and/or Glucose Intolerance.

Responder is defined as subject with a decrease greater than or equal to 25% in area under the curve for glucose on 2-hour oral glucose test from baseline to week 24 or last visit, for Cushing's patients with type-2 diabetes mellitus/impaired glucose tolerance. (NCT00569582)
Timeframe: Baseline to Week 24

Interventionparticipants (Number)
Mifepristone15

Reviews

56 reviews available for metyrapone and Cushing's Syndrome

ArticleYear
Cushing's disease: adrenal steroidogenesis inhibitors.
    Pituitary, 2022, Volume: 25, Issue:5

    Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Female; Humans; Hypokalemia; Ketoconazole; Male; Mety

2022
What is the role of medical therapy in adrenal-dependent Cushing's syndrome?
    Best practice & research. Clinical endocrinology & metabolism, 2020, Volume: 34, Issue:3

    Topics: Adrenal Gland Diseases; Cushing Syndrome; Humans; Ketoconazole; Metyrapone; Mitotane; Pituitary ACTH

2020
Adrenally Directed Medical Therapies for Cushing Syndrome.
    The Journal of clinical endocrinology and metabolism, 2021, 01-01, Volume: 106, Issue:1

    Topics: Adrenal Glands; Cushing Syndrome; Etomidate; Humans; Imidazoles; Ketoconazole; Metyrapone; Mitotane;

2021
Pneumocystis pneumonia can complicate medical treatment of hypercortisolism even in outpatients with Cushing's disease.
    Annales d'endocrinologie, 2020, Volume: 81, Issue:6

    Topics: ACTH Syndrome, Ectopic; Adult; Aged; Aged, 80 and over; Cushing Syndrome; Humans; Immunologic Defici

2020
Medical therapy in severe hypercortisolism.
    Best practice & research. Clinical endocrinology & metabolism, 2021, Volume: 35, Issue:2

    Topics: Cabergoline; Cushing Syndrome; Humans; Ketoconazole; Metyrapone; Mitotane

2021
Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
    Best practice & research. Clinical endocrinology & metabolism, 2021, Volume: 35, Issue:1

    Topics: Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzyme Inhibitors; Etomidate; Humans; Hydrocortisone; Im

2021
Therapy of endocrine disease: steroidogenesis enzyme inhibitors in Cushing's syndrome.
    European journal of endocrinology, 2015, Volume: 172, Issue:6

    Topics: Cushing Syndrome; Etomidate; Humans; Imidazoles; Ketoconazole; Metyrapone; Mitotane; Pyridines; Ster

2015
Therapeutic Strategies for the Treatment of Severe Cushing's Syndrome.
    Drugs, 2016, Volume: 76, Issue:4

    Topics: Animals; Cushing Syndrome; Etomidate; Humans; Hydrocortisone; Ketoconazole; Metyrapone

2016
Ectopic Cushing's syndrome due to a pheochromocytoma: a new case in the post-partum and review of literature.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2009, Volume: 25, Issue:9

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Cushing Syndrome; Female; Humans; Insulin; Metyrapone

2009
[Cushing's syndrome: special issues].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2009, Volume: 56, Issue:5

    Topics: Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocortical Hyperfunction; Adult; Child; Cush

2009
Drugs in the medical treatment of Cushing's syndrome.
    Expert opinion on emerging drugs, 2009, Volume: 14, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Antiparkinson Agents; Cabergoline; Cushing Sy

2009
Management of diabetes mellitus in Cushing's syndrome.
    Neuroendocrinology, 2010, Volume: 92 Suppl 1

    Topics: Cushing Syndrome; Diabetes Mellitus; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Insulin Resista

2010
Medical treatment of Cushing's syndrome: adrenal-blocking drugs and ketaconazole.
    Neuroendocrinology, 2010, Volume: 92 Suppl 1

    Topics: Cushing Syndrome; Enzyme Inhibitors; Etomidate; Humans; Ketoconazole; Metyrapone; Mitotane

2010
Pregnancy-induced Cushing's syndrome in recurrent pregnancies: case report and literature review.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2012, Volume: 52, Issue:1

    Topics: Adrenocorticotropic Hormone; Adult; Australia; Cushing Syndrome; Enzyme Inhibitors; Female; Humans;

2012
Advances in medical therapies for Cushing's syndrome.
    Discovery medicine, 2012, Volume: 13, Issue:69

    Topics: Animals; Bexarotene; Cushing Syndrome; Etomidate; Humans; Ketoconazole; Lapatinib; Metyrapone; Mifep

2012
The medical management of Cushing's syndrome during pregnancy.
    European journal of obstetrics, gynecology, and reproductive biology, 2013, Volume: 168, Issue:1

    Topics: Adrenalectomy; Cushing Syndrome; Female; Humans; Hydrocortisone; Ketoconazole; Metyrapone; Pre-Eclam

2013
[Cushing's syndrome during pregnancy].
    Presse medicale (Paris, France : 1983), 2002, Nov-09, Volume: 31, Issue:36

    Topics: Adrenal Cortex Neoplasms; Adult; Anti-Inflammatory Agents; Antimetabolites; Cushing Syndrome; Dexame

2002
ON THE DIAGNOSIS OF ADDISON'S DISEASE AND CUSHING'S SYNDROME BY LABORATORY METHODS.
    Mayo Clinic proceedings, 1964, Volume: 39

    Topics: 17-Ketosteroids; Addison Disease; Adrenal Insufficiency; Adrenocorticotropic Hormone; Biochemical Ph

1964
[METHODOLOGICAL DATA ON THE DYNAMIC EVALUATION OF THE DIENCEPHALON-ANTERIOR PITUITARY-ADRENAL CORTEX SYSTEM].
    Archivio per le scienze mediche, 1964, Volume: 117

    Topics: Acromegaly; Addison Disease; Adrenal Cortex; Adrenocorticotropic Hormone; Cushing Syndrome; Dexameth

1964
Dynamic tests in the diagnosis and differential diagnosis of Cushing's syndrome.
    Journal of endocrinological investigation, 2003, Volume: 26, Issue:7 Suppl

    Topics: Adrenal Cortex Function Tests; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethasone; Dia

2003
[Urinary tetrahydro-11-deoxycortisol (THS)].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 8

    Topics: Addison Disease; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Biomarkers; Chromatography, Pa

2005
[Medical treatment for Cushing's syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 2008, Volume: 66, Issue:1

    Topics: Aminoglutethimide; Aromatase Inhibitors; Cushing Syndrome; Humans; Ketoconazole; Metyrapone; Steroid

2008
Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement.
    The Journal of clinical endocrinology and metabolism, 2008, Volume: 93, Issue:7

    Topics: ACTH Syndrome, Ectopic; Adrenal Insufficiency; Adrenalectomy; Adrenocorticotropic Hormone; Cushing S

2008
Normal and abnormal function of the hypothalamic-pituitary-adrenocortical system in man.
    Endocrine reviews, 1984,Summer, Volume: 5, Issue:3

    Topics: 17-Hydroxycorticosteroids; Acromegaly; Adenoma, Chromophobe; Adolescent; Adrenocorticotropic Hormone

1984
Hypercortisolism.
    Clinics in laboratory medicine, 1984, Volume: 4, Issue:4

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Cushing Syn

1984
Treatment of Cushing's disease in children.
    Acta paediatrica Scandinavica, 1982, Volume: 71, Issue:1

    Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Child; Cushing Syndrom

1982
The relationship between the pineal gland and the pituitary--adrenal axis in health, endocrine and psychiatric conditions.
    Psychoneuroendocrinology, 1983, Volume: 8, Issue:1

    Topics: Adenoma; Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Circadian Rhythm; Cushing Syndr

1983
[Cushing's syndrome: a diagnostic strategy].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1984, Apr-05, Volume: 60, Issue:15

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethas

1984
Pathophysiology and treatment of Cushing's disease.
    Progress in clinical and biological research, 1982, Volume: 87

    Topics: Adrenal Glands; Adrenalectomy; Aminoglutethimide; Cushing Syndrome; Delayed-Action Preparations; Hum

1982
The medical treatment of Cushing's syndrome.
    Endocrine reviews, 1993, Volume: 14, Issue:4

    Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Aminoglutethimide; Animals; Bromocriptine; Cushing Syndrom

1993
[Non-invasive therapy of Cushing's syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1994, Sep-10, Volume: 83, Issue:9

    Topics: Aminoglutethimide; Betamethasone; Bromocriptine; Clinical Trials as Topic; Cushing Syndrome; Cyprohe

1994
Feline adrenocortical diseases: Part I--Hyperadrenocorticism.
    Seminars in veterinary medicine and surgery (small animal), 1994, Volume: 9, Issue:3

    Topics: Adrenocorticotropic Hormone; Animals; Cat Diseases; Cats; Cushing Syndrome; Dexamethasone; Diagnosis

1994
Steroid biosynthesis inhibitors in Cushing's syndrome.
    The Clinical investigator, 1994, Volume: 72, Issue:7

    Topics: Adrenal Cortex Hormones; Aminoglutethimide; Cushing Syndrome; Dihydrotestosterone; Etomidate; Humans

1994
Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    The Journal of steroid biochemistry and molecular biology, 1994, Volume: 49, Issue:4-6

    Topics: 3-Hydroxysteroid Dehydrogenases; Aminoglutethimide; Cushing Syndrome; Dihydrotestosterone; Etomidate

1994
[Clinical usefulness of pharmacological treatment of Cushing's syndrome].
    Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52, Issue:3

    Topics: Administration, Oral; Aminoglutethimide; Cushing Syndrome; Dihydrotestosterone; Humans; Ketoconazole

1994
[Cushing syndrome in children].
    Annales de pediatrie, 1993, Volume: 40, Issue:7

    Topics: Adolescent; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hor

1993
[Metopiron test].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl 2

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Cushing Syndrome; Humans; Hypothalamo-Hypophyse

1997
[Metyrapone test].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl 2

    Topics: ACTH Syndrome, Ectopic; Adrenal Cortex Diseases; Adrenal Cortex Function Tests; Adrenal Insufficienc

1997
The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states.
    Endocrine reviews, 1998, Volume: 19, Issue:5

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Anti-Inflammatory Agents; Circadian Rhythm; Cor

1998
[Diagnostic pitfalls in Cushing's disease].
    Annales d'endocrinologie, 2000, Volume: 61, Issue:3

    Topics: Circadian Rhythm; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethasone; Diagnosis, Diffe

2000
Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone.
    Clinical endocrinology, 2001, Volume: 54, Issue:2

    Topics: Abortion, Therapeutic; Adolescent; Adrenal Glands; Cesarean Section; Cushing Syndrome; Female; Fetal

2001
[Determination of serum (and urinary) 17-hydroxycorticosteroids and 17-ketosteroids].
    Nihon rinsho. Japanese journal of clinical medicine, 1976, Volume: 34 suppl

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Addison Disease; Adolescent; Adrenocorticotropic Hormone

1976
Pathophysiology of Cushing's disease.
    Pathobiology annual, 1979, Volume: 9

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Cushing Syndrome; Gonadotropins, Pituitary; Gr

1979
Topical steroids and hypothalamo-pituitary-adrenal suppression: a review.
    The Australasian journal of dermatology, 1978, Volume: 19, Issue:3

    Topics: Administration, Topical; Adrenal Cortex Hormones; Circadian Rhythm; Cushing Syndrome; Humans; Hypoth

1978
[Drug therapy of pituitary tumors].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Mar-10, Volume: 80, Issue:3

    Topics: Bromocriptine; Cushing Syndrome; Cyproheptadine; Female; Humans; Male; Metyrapone; Octreotide; Pitui

1991
The treatment of Cushing's syndrome.
    Clinical endocrinology, 1991, Volume: 34, Issue:6

    Topics: Adrenalectomy; Cushing Syndrome; Humans; Metyrapone; Pituitary Gland

1991
Appropriate laboratory testing in the screening and work-up of Cushing's syndrome.
    American journal of clinical pathology, 1988, Volume: 90, Issue:3

    Topics: Adenoma; Adrenocorticotropic Hormone; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethaso

1988
Disorders of the hypothalamic-pituitary-adrenal axis.
    Clinics in endocrinology and metabolism, 1985, Volume: 14, Issue:1

    Topics: Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adrenal Hyperplasia, Congenital; Adrenal Insuffic

1985
Is it possible to diagnose pituitary-dependent Cushing's disease?
    Annals of clinical biochemistry, 1985, Volume: 22 ( Pt 6)

    Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotropic Hor

1985
Cushing's syndrome: update of diagnosis and management.
    Mayo Clinic proceedings, 1986, Volume: 61, Issue:1

    Topics: Adenoma; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cushin

1986
Cushing's syndrome.
    Clinics in endocrinology and metabolism, 1985, Volume: 14, Issue:4

    Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Alcoho

1985
Primary adrenocortical nodular dysplasia, a distinct subtype of Cushing's syndrome. Case report and review of the literature.
    The American journal of medicine, 1986, Volume: 80, Issue:5

    Topics: Adolescent; Adrenal Cortex; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocortical Hyperfunc

1986
[New endocrine disorders attracting current interest--adrenal system].
    Horumon to rinsho. Clinical endocrinology, 1969, Volume: 17, Issue:5

    Topics: Addison Disease; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Ho

1969
[ACTH--how to read its figures].
    Nihon rinsho. Japanese journal of clinical medicine, 1971, Volume: 29

    Topics: Addison Disease; Adrenocorticotropic Hormone; Biological Assay; Blood Chemical Analysis; Circadian R

1971
[Circadian rhythm of the hypothalamo-pituitary-adrenal system].
    Saishin igaku. Modern medicine, 1972, Volume: 27, Issue:4

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Circ

1972
[Aspect of hormones and hypertension].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1969, Jul-10, Volume: 58, Issue:7

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Age Factors; Aged; Aldosterone; Blood Pressure; Catechol

1969

Trials

9 trials available for metyrapone and Cushing's Syndrome

ArticleYear
Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone.
    Annals of clinical biochemistry, 2011, Volume: 48, Issue:Pt 5

    Topics: Chromatography, Liquid; Cushing Syndrome; Diagnostic Techniques and Procedures; Drug Monitoring; Fal

2011
[Changes in plasma level of corticotropin after intravenous injection of metyrapone. Value of this test in pituitary pathology].
    La Nouvelle presse medicale, 1977, Apr-16, Volume: 6, Issue:16

    Topics: Adrenocorticotropic Hormone; Adult; Clinical Trials as Topic; Cushing Syndrome; Drug Tolerance; Huma

1977
ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.
    Acta endocrinologica, 1978, Volume: 89, Issue:3

    Topics: Administration, Oral; Adrenocorticotropic Hormone; Adult; Bromocriptine; Clinical Trials as Topic; C

1978
Treatment of major depression with steroid suppressive drugs.
    The Journal of steroid biochemistry and molecular biology, 1991, Volume: 39, Issue:2

    Topics: Adrenocortical Hyperfunction; Adult; Aged; Aminoglutethimide; Cushing Syndrome; Depressive Disorder;

1991
Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man.
    Neuroendocrinology, 1990, Volume: 51, Issue:1

    Topics: Adult; Arginine; Clonidine; Cushing Syndrome; Dexamethasone; Female; Growth Hormone; Growth Hormone-

1990
Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease.
    Clinical endocrinology, 1990, Volume: 33, Issue:4

    Topics: Adolescent; Adrenalectomy; Adult; Aged; Child; Cushing Syndrome; Female; Follow-Up Studies; Humans;

1990
Aminoglutethimide and metyrapone in the management of Cushing's syndrome.
    Acta endocrinologica, 1985, Volume: 109, Issue:4

    Topics: ACTH Syndrome, Ectopic; Adolescent; Adrenal Gland Neoplasms; Adult; Aminoglutethimide; Clinical Tria

1985
The effect of metyrapone on aldosterone secretion in man.
    Acta endocrinologica, 1967, Volume: 56, Issue:3

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Adult; Aldosterone; Body We

1967
Experience with a rapid oral metyrapone test and the plasma ACTH content in determining the cause of Cushing's syndrome.
    Metabolism: clinical and experimental, 1969, Volume: 18, Issue:3

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adolescent; Adrenal Gland Diseases; Adrenal Gla

1969

Other Studies

324 other studies available for metyrapone and Cushing's Syndrome

ArticleYear
Cushing's syndrome: development of highly potent and selective CYP11B1 inhibitors of the (pyridylmethyl)pyridine type.
    Journal of medicinal chemistry, 2013, Aug-08, Volume: 56, Issue:15

    Topics: Animals; Cell Line; Cricetinae; Cushing Syndrome; Cytochrome P-450 CYP11B2; Humans; Liver; Models, M

2013
Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Cushing Syndrome; Humans; Hydrocortisone; Immunoassay; Ketoconazole; Metyrapone; Reproducibility of

2022
Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients.
    European journal of endocrinology, 2022, Aug-01, Volume: 187, Issue:2

    Topics: Adrenocorticotropic Hormone; Androstenedione; Chromatography, Liquid; Cortodoxone; Cushing Syndrome;

2022
Cushing syndrome as a failed cardiac screen in a patient with McCune-Albright syndrome: a case report.
    Journal of medical case reports, 2022, Sep-15, Volume: 16, Issue:1

    Topics: Cushing Syndrome; Dexamethasone; Fibrous Dysplasia, Polyostotic; GTP-Binding Protein alpha Subunits;

2022
Pneumocystis pneumonia in patients with Cushing's syndrome: A French multicenter retrospective study.
    Annales d'endocrinologie, 2023, Volume: 84, Issue:1

    Topics: Cushing Syndrome; Humans; Hydrocortisone; Metyrapone; Pneumonia, Pneumocystis; Retrospective Studies

2023
LC-MS/MS method for simultaneous quantification of osilodrostat and metyrapone in human plasma from patients treated for Cushing's Syndrome.
    Journal of pharmaceutical and biomedical analysis, 2023, May-10, Volume: 228

    Topics: Chromatography, Liquid; Cushing Syndrome; Humans; Metyrapone; Tandem Mass Spectrometry

2023
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome.
    European journal of endocrinology, 2020, Volume: 183, Issue:1

    Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Coronavirus Infections;

2020
Practical Considerations for the Management of Cushing's Disease and COVID-19: A Case Report.
    Frontiers in endocrinology, 2020, Volume: 11

    Topics: Aged; Anti-Inflammatory Agents; Antimetabolites; Betacoronavirus; Coronavirus Infections; COVID-19;

2020
Approach to the Patient Treated with Steroidogenesis Inhibitors.
    The Journal of clinical endocrinology and metabolism, 2021, 06-16, Volume: 106, Issue:7

    Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Enzyme Inhibitors; Female; Humans; Imidazoles;

2021
A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.
    Clinical endocrinology, 2017, Volume: 87, Issue:5

    Topics: Adult; Cushing Syndrome; Female; Humans; Ketoconazole; Male; Metyrapone; Middle Aged; Pharmacogeneti

2017
Cyclical Cushing's: how best to catch the ups and downs.
    BMJ case reports, 2017, Jul-13, Volume: 2017

    Topics: Adrenalectomy; Aged; Cushing Syndrome; Humans; Hydrocortisone; Male; Metyrapone; Treatment Outcome

2017
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
    Endocrine, 2018, Volume: 61, Issue:1

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antimetabolites, Antineoplastic; An

2018
Preoperative medical treatment in Cushing's syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN.
    European journal of endocrinology, 2018, Volume: 178, Issue:4

    Topics: Adrenal Glands; Adult; Aged; Cushing Syndrome; Databases, Factual; Europe; Female; Humans; Ketoconaz

2018
Unexpected adverse effect of metyrapone: A case report.
    Clinical endocrinology, 2018, Volume: 89, Issue:1

    Topics: Adult; Cushing Syndrome; Humans; Male; Metyrapone

2018
Behaviour disorder caused by Cushing's syndrome in an older person.
    Age and ageing, 2018, 11-01, Volume: 47, Issue:6

    Topics: Aged, 80 and over; Antipsychotic Agents; Cushing Syndrome; Diagnosis, Differential; Enzyme Inhibitor

2018
Metyrapone treatment in Cushing's syndrome: a real-life study.
    Endocrine, 2018, Volume: 62, Issue:3

    Topics: Adult; Aged; Circadian Rhythm; Cushing Syndrome; Enzyme Inhibitors; Female; Humans; Hydrocortisone;

2018
Should we avoid using ketoconazole in patients with severe Cushing’s syndrome and increased levels of liver enzymes?
    European journal of endocrinology, 2018, Oct-12, Volume: 179, Issue:5

    Topics: Adult; Cushing Syndrome; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Ketoconazole;

2018
Hypokalaemic metabolic alkalosis, hypertension and diabetes: what is the link.
    BMJ case reports, 2019, Jan-18, Volume: 12, Issue:1

    Topics: Alkalosis; Cushing Syndrome; Diabetes Mellitus; Female; Humans; Hypertension; Hypokalemia; Metyrapon

2019
Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.
    The Journal of clinical endocrinology and metabolism, 2019, 08-01, Volume: 104, Issue:8

    Topics: Aldosterone; Cell Culture Techniques; Cortodoxone; Cushing Syndrome; Cytochrome P-450 CYP11B2; Enzym

2019
[A case of acute respiratory distress syndrome caused by cryptococcus and cytomegalovirus co-infection after Cushing's syndrome treatment].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2013, Volume: 87, Issue:1

    Topics: Aged, 80 and over; Coinfection; Cryptococcosis; Cushing Syndrome; Cytomegalovirus Infections; Female

2013
Case report: Beneficial effect of 11β-hydroxylase inhibitor in the management of an elderly patient with an androgen-producing inoperable adrenal tumor.
    Geriatrics & gerontology international, 2013, Volume: 13, Issue:2

    Topics: Adrenal Gland Neoplasms; Aged, 80 and over; Androgens; Cushing Syndrome; Dexamethasone; Enzyme Inhib

2013
Rapid control of severe neoplastic hypercortisolism with metyrapone and ketoconazole.
    European journal of endocrinology, 2015, Volume: 172, Issue:4

    Topics: ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Cushing Synd

2015
Neonatal McCune-Albright syndrome with systemic involvement: a case report.
    Journal of medical case reports, 2015, Sep-04, Volume: 9

    Topics: Cafe-au-Lait Spots; Cushing Syndrome; Diagnosis, Differential; Failure to Thrive; Fatal Outcome; Fem

2015
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:11

    Topics: ACTH-Secreting Pituitary Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschoo

2015
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:11

    Topics: ACTH-Secreting Pituitary Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschoo

2015
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:11

    Topics: ACTH-Secreting Pituitary Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschoo

2015
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients.
    The Journal of clinical endocrinology and metabolism, 2015, Volume: 100, Issue:11

    Topics: ACTH-Secreting Pituitary Adenoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschoo

2015
[Cushing's syndrome in a manic patient with a long-standing bipolar disorder: cause or coincidence?].
    Tijdschrift voor psychiatrie, 2015, Volume: 57, Issue:10

    Topics: Aged; Bipolar Disorder; Cushing Syndrome; Diagnosis, Differential; Female; Humans; Metyrapone

2015
[Recovery of Cushing syndrome revealing McCune-Albright syndrome].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2016, Volume: 23, Issue:1

    Topics: Child; Cushing Syndrome; Enzyme Inhibitors; Female; Fibrous Dysplasia, Polyostotic; Follow-Up Studie

2016
[Indications and future perspectives in the pharmacological treatment of hypercortisolism].
    Recenti progressi in medicina, 2016, Volume: 107, Issue:3

    Topics: Adenoma; Cushing Syndrome; Humans; Hydrocortisone; Italy; Ketoconazole; Metyrapone; Pituitary Neopla

2016
[Pharmacological treatment in adrenal Cushing's syndrome.]
    Recenti progressi in medicina, 2016, Volume: 107, Issue:11

    Topics: Cushing Syndrome; Humans; Ketoconazole; Metyrapone

2016
A successful case of pregnancy in a woman with ACTH-independent Cushing's syndrome treated with ketoconazole and metyrapone.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2017, Volume: 33, Issue:5

    Topics: Adult; Cushing Syndrome; Drug Therapy, Combination; Female; Humans; Ketoconazole; Metyrapone; Pregna

2017
A patient with ectopic cortisol production derived from malignant testicular masses.
    Nature clinical practice. Endocrinology & metabolism, 2008, Volume: 4, Issue:12

    Topics: Adrenal Rest Tumor; Adrenocortical Carcinoma; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; H

2008
Transfer of metyrapone and its metabolite, rac-metyrapol, into breast milk.
    Journal of human lactation : official journal of International Lactation Consultant Association, 2009, Volume: 25, Issue:4

    Topics: Adult; Area Under Curve; Breast Feeding; Chromatography, High Pressure Liquid; Cushing Syndrome; Enz

2009
Profound neutropenia resulting from metyrapone-induced adrenal crisis.
    American journal of hematology, 2009, Volume: 84, Issue:11

    Topics: Adrenal Insufficiency; Antimetabolites; Cushing Syndrome; Female; Humans; Metyrapone; Middle Aged; N

2009
Ketoconazole treatment for Cushing syndrome in McCune-Albright syndrome.
    The Journal of pediatrics, 2009, Volume: 154, Issue:3

    Topics: Adrenergic Agents; Adrenocorticotropic Hormone; Aminoglutethimide; Antifungal Agents; Chemical and D

2009
Endothelial dysfunction aassociated with hypercortisolism is reversible in Cushing's syndrome.
    Endocrine journal, 2010, Volume: 57, Issue:3

    Topics: Adult; Aged; Blood Flow Velocity; Carotid Arteries; Cushing Syndrome; Endothelium, Vascular; Humans;

2010
Cortisol measurement in patients receiving metyrapone therapy.
    Annals of clinical biochemistry, 2010, Volume: 47, Issue:Pt 6

    Topics: Chromatography, Liquid; Cushing Syndrome; Humans; Hydrocortisone; Immunoassay; Mass Spectrometry; Me

2010
Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:9

    Topics: Adolescent; Adult; Aged; Antimetabolites; Antineoplastic Agents; Cushing Syndrome; Drug Therapy, Com

2011
Type 2 diabetes identified in pregnancy secondary to Cushing's syndrome.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2011, Volume: 31, Issue:6

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Cushing Syndrome; Diabetes Mellitus, Type 2

2011
Assessment of long-term efficacy and safety of metyrapone monotherapy in a patient with ACTH-independent macronodular adrenal hyperplasia.
    Endocrine, 2012, Volume: 41, Issue:1

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Dose-Response Relationship, Dru

2012
Pathophysiology of hypercortisolism in depression: pituitary and adrenal responses to low glucocorticoid feedback.
    Acta psychiatrica Scandinavica, 2012, Volume: 125, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Case-Control Studies; Cushing Syndrome; Depressive Disorder, Maj

2012
Comparison of serum cortisol measurement by immunoassay and liquid chromatography-tandem mass spectrometry in patients receiving the 11β-hydroxylase inhibitor metyrapone.
    Annals of clinical biochemistry, 2012, Volume: 49, Issue:Pt 2

    Topics: Cushing Syndrome; Drug Monitoring; Humans; Hydrocortisone; Metyrapone; Steroid 11-beta-Hydroxylase

2012
A reappraisal of the medical therapy with steroidogenesis inhibitors in Cushing's syndrome.
    Clinical endocrinology, 2012, Volume: 77, Issue:5

    Topics: Adolescent; Adult; Aged; Antimetabolites; Child; Cushing Syndrome; Female; Humans; Ketoconazole; Mal

2012
Cushing's syndrome during pregnancy: curative adrenalectomy at 31 weeks gestation.
    European journal of obstetrics, gynecology, and reproductive biology, 2002, Nov-15, Volume: 105, Issue:2

    Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Cushing Syndrome; Female; Gestational A

2002
[A new synthetic inhibitor of adrenal cortex hormones: 2-methyl-1,2-bis(3-pyridyl)-1-propanone (SU 4885, Metopirone)].
    Minerva medica, 1962, May-05, Volume: 53

    Topics: Adrenal Cortex Hormones; Cushing Syndrome; Humans; Liver Cirrhosis; Metyrapone; Pyridines

1962
EFFECT OF LONG-TERM ADMINISTRATION OF METYRAPONE AND DEXAMETHASONE IN A PATIENT WITH CUSHING'S SYNDROME.
    Acta endocrinologica, 1963, Volume: 43

    Topics: Cushing Syndrome; Dexamethasone; Humans; Metyrapone; Mineralocorticoid Receptor Antagonists

1963
EFFECT OF METOPIRONE IN A PATIENT WITH ADRENAL CORTICAL CARCINOMA.
    Acta endocrinologica, 1963, Volume: 44

    Topics: 17-Ketosteroids; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenocortical Carcinoma; Cushing

1963
[TESTING OF THE FUNCTION OF THE PITUITARY GLAND AND THE ADRENAL GLANDS WITH METOPIRONE].
    Orvosi hetilap, 1963, Nov-03, Volume: 104

    Topics: 17-Ketosteroids; Addison Disease; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenal Glands;

1963
[ENDOCRINOLOGICAL OBSERVATIONS ON CUSHING'S SYNDROME].
    Nihon Sanka Fujinka Gakkai zasshi, 1963, Volume: 15

    Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenocorticotropic Ho

1963
[SIGNIFICANCE OF THE EVALUATION OF URINARY PREGNANTRIOL IN SOME ADRENAL ENDOCRINE DISORDERS: FINDINGS IN BASAL CONDITIONS AND AFTER TREATMENTS STIMULATING OR INHIBITING THE ADRENAL CORTEX].
    Archivio di patologia e clinica medica, 1964, Volume: 40

    Topics: Adolescent; Adrenal Cortex; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocortical Hyperfun

1964
[THE METOPIRONE TEST IN THE DIFFERENTIAL DIAGNOSIS OF VARIOUS ENDOCRINE DISORDERS OF CHILDHOOD].
    Rivista di clinica pediatrica, 1963, Volume: 72

    Topics: Adolescent; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Carbohydrate Metabolism; Child; Cu

1963
[INDIRECT EVALUATION OF CORTICOTROPIN ACTIVITY IN VARIOUS SITUATIONS OF PITUITARY-ADRENAL PHYSIOPATHOLOGY].
    Minerva medica, 1964, Feb-21, Volume: 55

    Topics: Acromegaly; Adrenocorticotropic Hormone; Anorexia Nervosa; Cushing Syndrome; Dexamethasone; Humans;

1964
[EXPLORATION OF THE ACTH HYPOPHYSEAL RESERVE WITH METOPIRONE IN DIFFERENT ENDOCRINOPATHIES].
    Anales de la Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay, 1963, Volume: 48

    Topics: 17-Ketosteroids; Acromegaly; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Clinical Lab

1963
CUSHING'S SYNDROME CO-EXISTING WITH HYPERTHYROIDISM. REPORT OF A CASE AND SOME METABOLIC OBSERVATIONS.
    Acta medica Scandinavica, 1964, Volume: 175

    Topics: Adrenal Cortex Hormones; Adrenalectomy; Adrenocorticotropic Hormone; Blood Chemical Analysis; Choles

1964
ADRENAL FUNCTION AND THE COMPLICATIONS OF DIABETES MELLITUS.
    Lancet (London, England), 1964, Sep-12, Volume: 2, Issue:7359

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Blood Chemical Analysis; Carbon Isotopes; Cush

1964
PROBABILITIES OF PITUITARY-ADRENAL RESPONSIVENESS AFTER STEROID THERAPY.
    Annals of internal medicine, 1964, Volume: 61

    Topics: Adolescent; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Biomedical Research; Cushing Syndr

1964
MEDICAL GRAND ROUNDS FROM THE UNIVERSITY OF ALABAMA MEDICAL CENTER.
    Southern medical journal, 1964, Volume: 57

    Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Diagnosis, Differenti

1964
[CONTRIBUTION TO THE FUNCTIONAL STUDY OF THE PITUITARY-ADRENAL AXIS WITH METHOPYRAPONE (2-METHYL-1,2-BIS(3-PYRIDYL)-1-PROPANONE)].
    Endocrinologia e scienza della costituzione, 1964, Volume: 28

    Topics: Adolescent; Adrenal Glands; Adrenocortical Hyperfunction; Child; Cushing Syndrome; Hirsutism; Humans

1964
[ADRENAL CORTEX HYPERPLASIA ASSOCIATED WITH HYPERTROPHY OF THE THYMUS GLAND AND ACANTHOSIS NIGICANS IN A CHILD].
    Revista argentina de endocrinologia y metabolismo, 1964, Volume: 10

    Topics: Acanthosis Nigricans; Adrenal Cortex; Adrenal Gland Diseases; Adrenocortical Hyperfunction; Adrenoco

1964
MULTIPLE BRONCHIAL ADENOMAS, CUSHING'S SYNDROME AND HYPOKALEMIC ALKALOSIS. REPORT OF A CASE.
    Diseases of the chest, 1964, Volume: 46

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Alk

1964
DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME AND OBESITY ASSOCIATED WITH STRIAE.
    Lancet (London, England), 1964, Nov-21, Volume: 2, Issue:7369

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Betamethasone; Cushing Synd

1964
[THE DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME].
    Deutsche medizinische Wochenschrift (1946), 1964, Dec-11, Volume: 89

    Topics: Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Cushing Syndrome

1964
[STUDIES ON THE DIAGNOSTIC USE OF METOPIRONE (11-BETA-HYDROXYLASE INHIBITOR) IN DISEASES OF THE PITUITARY AND ADRENAL CORTEX].
    Nihon Naibunpi Gakkai zasshi, 1964, Dec-20, Volume: 40

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Blo

1964
USE OF METHOPYRAPONE (SU-4885) IN THE STUDY OF PITUITARY-ADRENAL RESPONSE IN PATIENTS UNDER CORTICOSTEROID TREATMENT.
    The Journal of clinical endocrinology and metabolism, 1965, Volume: 25

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Cus

1965
CUSHING'S SYNDROME FOLLOWING PARTIAL ADRENALECTOMY AND COMPLETE HYPOPHYSECTOMY.
    Acta endocrinologica, 1965, Volume: 48

    Topics: 17-Ketosteroids; Adrenalectomy; Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Humans

1965
A STUDY OF PITUITARY FUNCTION AFTER INTRASELLAR IMPLANTATION OF 90YTTRIUM.
    The Journal of clinical endocrinology and metabolism, 1965, Volume: 25

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acromegaly; Basal Metabolism; Breast Neoplasms; Cushing

1965
CLINICAL ASSESSMENT OF THE PERORAL METOPIRONE TEST.
    Acta medica Scandinavica, 1965, Volume: 178

    Topics: Adenoma; Adenoma, Chromophobe; Adrenalectomy; Adrenocorticotropic Hormone; Cushing Syndrome; Diabete

1965
[Pituitary reactions to adrenalectomy for Cushing's syndrome and to the administration of SU 4885].
    Problemes actuels d'endocrinologie et de nutrition, 1961, Volume: 5, Issue:3

    Topics: Adrenalectomy; Cushing Syndrome; Humans; Metyrapone; Pituitary Diseases; Pituitary Gland; Pyridines

1961
Metyrapone for delirium due to Cushing's syndrome induced by occult ectopic adrenocorticotropic hormone secretion.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:7

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Cushing Syndrome; Delirium; Enzyme Inhibitors;

2004
[Treatment with metyrapone of Cushing's syndrome revealing McCune-Albright syndrome].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2005, Volume: 12, Issue:7

    Topics: Adrenal Hyperplasia, Congenital; Cushing Syndrome; Enzyme Inhibitors; Female; Fibrous Dysplasia, Pol

2005
Expression of the human glucocorticoid receptor splice variants alpha, beta, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:11

    Topics: Adult; Aged; Case-Control Studies; Cushing Syndrome; Female; Humans; Hydrocortisone; Leukocytes, Mon

2005
Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease.
    Hormone research, 2005, Volume: 64, Issue:3

    Topics: Adrenalectomy; Child; Contraindications; Cushing Syndrome; Etomidate; Humans; Hydrocortisone; Ketoco

2005
Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy.
    Journal of endocrinological investigation, 2006, Volume: 29, Issue:2

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Cushing Syndrome; Enzyme Inhibitors; Female;

2006
Pharmacological management of Cushing's syndrome: an update.
    Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:8

    Topics: Cushing Syndrome; Dopamine Antagonists; Hormone Antagonists; Humans; Hypothalamo-Hypophyseal System;

2007
Reduction in salivary cortisol concentration correlates with resolution of psychosis in Cushing's syndrome.
    The Journal of neuropsychiatry and clinical neurosciences, 2008,Winter, Volume: 20, Issue:1

    Topics: Antimetabolites; Cushing Syndrome; Humans; Hydrocortisone; Male; Metyrapone; Middle Aged; Psychotic

2008
Prolonged remission of severe Cushing syndrome without adrenalectomy in an infant with McCune-Albright syndrome.
    The Journal of pediatrics, 2008, Volume: 152, Issue:6

    Topics: Adrenalectomy; Adrenergic Agents; Aminoglutethimide; Child; Cushing Syndrome; Enzyme Inhibitors; Fem

2008
The assessment of patients with Cushing's syndrome before and after pituitary implantation.
    Proceedings of the Royal Society of Medicine, 1967, Volume: 60, Issue:9

    Topics: 17-Ketosteroids; Cushing Syndrome; Dexamethasone; Humans; Metyrapone; Yttrium Isotopes

1967
Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission.
    Archives of internal medicine, 1983, Volume: 143, Issue:5

    Topics: Adenoma, Chromophobe; Adrenocorticotropic Hormone; Adult; Aminoglutethimide; Cushing Syndrome; Femal

1983
Cushing's disease: clinical and laboratory response to bromocriptine therapy.
    Journal of endocrinological investigation, 1984, Volume: 7, Issue:6

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Bromocri

1984
Sodium valproate and metyrapone for pituitary-dependent Cushing's disease.
    Lancet (London, England), 1984, Sep-15, Volume: 2, Issue:8403

    Topics: Adrenal Glands; Adult; Cushing Syndrome; Drug Therapy, Combination; Female; Humans; Metyrapone; Pitu

1984
Clotting changes in Cushing's syndrome: elevated factor VIII activity.
    Folia haematologica (Leipzig, Germany : 1928), 1983, Volume: 110, Issue:2

    Topics: Adrenalectomy; Blood Coagulation; Blood Coagulation Tests; Cushing Syndrome; Factor VIII; Female; Hu

1983
Suppression of ACTH by cortisol in dexamethasone-nonsuppressible Cushing's disease.
    The New England journal of medicine, 1980, Jan-31, Volume: 302, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Depression, Chemica

1980
Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 50, Issue:5

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Fema

1980
Twelve-hour cycles of adrenocorticotropin and cortisol secretion in Cushing's disease.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 51, Issue:5

    Topics: Adrenocorticotropic Hormone; Circadian Rhythm; Cushing Syndrome; Dexamethasone; Female; Humans; Hydr

1980
Successful therapy of an ACTH-producing gastric carcinoid APUD tumor: report of a case and review of the literature.
    Cancer, 1980, Sep-01, Volume: 46, Issue:5

    Topics: Adrenocorticotropic Hormone; Apudoma; Carcinoid Tumor; Cushing Syndrome; Cytoplasmic Granules; Femal

1980
Regulation of prolactin secretion in patients with Cushing's disease. A comparative study on the effects of dexamethasone, lysine vasopressin and ACTH on prolactin secretion by the rat pituitary gland in vitro.
    Neuroendocrinology, 1981, Volume: 32, Issue:3

    Topics: Adrenocorticotropic Hormone; Adult; Animals; Cushing Syndrome; Dexamethasone; Dopamine; Female; Huma

1981
The George M. Kober lecture. "Cushing's syndrome--1980.".
    Transactions of the Association of American Physicians, 1980, Volume: 93

    Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Humans; Hydrocortisone; Metyrapone; Pi

1980
Cyproheptadine in the control of Cushing's disease.
    The Johns Hopkins medical journal, 1981, Volume: 149, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Cyproheptadine; Female; Humans; Hydrocortisone

1981
Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978).
    The American journal of medicine, 1981, Volume: 71, Issue:5

    Topics: Adenoma; Adolescent; Adrenal Cortex Function Tests; Adrenal Cortex Neoplasms; Adrenocorticotropic Ho

1981
Prolonged remission in florid Cushing's syndrome following metyrapone treatment.
    Clinical endocrinology, 1981, Volume: 14, Issue:5

    Topics: Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Female; Humans; Hydrocortisone; Male; Metyrapon

1981
A case of dexamethasone non-suppressible Cushing's disease hardly differentiated from ectopic ACTH syndrome.
    Endocrinologia japonica, 1983, Volume: 30, Issue:1

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dexamethasone; Diagnos

1983
Concomitant falls of plasma cortisol and ACTH levels in a case of Cushing's disease during treatment with trilostane.
    Acta endocrinologica, 1984, Volume: 105, Issue:1

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Dihydrotestosterone;

1984
The value of beta-lipotrophin measurement during the short metyrapone test in patients with pituitary diseases and in Cushing's syndrome.
    Acta endocrinologica, 1984, Volume: 105, Issue:4

    Topics: Adrenocorticotropic Hormone; Adult; beta-Lipotropin; Cortodoxone; Cushing Syndrome; Female; Humans;

1984
Atypical case of alcohol-induced Cushingoid syndrome.
    British medical journal (Clinical research ed.), 1981, Apr-04, Volume: 282, Issue:6270

    Topics: Alcoholism; Cushing Syndrome; Female; Humans; Metyrapone; Middle Aged

1981
The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    The American journal of medicine, 1983, Volume: 74, Issue:4

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adult; Aged; Cortodoxone; Cushing Syndrome; Dexamethasone; Dia

1983
[Successful conservative treatment of bronchial carcinoid with Cushing's syndrome due to ectopic ACTH production].
    Deutsche medizinische Wochenschrift (1946), 1983, Aug-05, Volume: 108, Issue:31-32

    Topics: ACTH Syndrome, Ectopic; Bronchial Neoplasms; Carcinoid Tumor; Cushing Syndrome; Cyclophosphamide; Do

1983
Synthesis of radioiodinated metyrapone--a potential adrenal imaging agent.
    The International journal of applied radiation and isotopes, 1983, Volume: 34, Issue:6

    Topics: Adrenal Glands; Animals; Cushing Syndrome; Female; Humans; Iodine Radioisotopes; Isotope Labeling; M

1983
Cushing's syndrome in pregnancy--treatment with metyrapone.
    Clinical endocrinology, 1982, Volume: 16, Issue:3

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Cushing Syndrome; Female; Humans; Metyrapone; Pregnancy; Pr

1982
[Cushing's syndrome: metyrapone therapy as a preparation for selective trans-sphenoidal adenomectomy].
    Endokrynologia Polska, 1982, Volume: 33, Issue:4-6

    Topics: Adenoma; Adolescent; Adult; Cushing Syndrome; Female; Humans; Male; Metyrapone; Middle Aged; Pituita

1982
[Cushing's syndrome. Medical treatment of adrenal hypercorticism].
    Hormone research, 1980, Volume: 13, Issue:4-5

    Topics: Adrenal Gland Neoplasms; Aminoglutethimide; Androstanols; Bromocriptine; Cushing Syndrome; Cyprohept

1980
Deoxycorticosterone and aldosterone excretion in Cushing's syndrome.
    Metabolism: clinical and experimental, 1980, Volume: 29, Issue:2

    Topics: Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenal Glands; Adult; Aged; Aldosterone; Carcinoma;

1980
Misdiagnosis of Cushing's syndrome in a patient receiving rifampicin therapy for tuberculosis.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1995, Volume: 27, Issue:3

    Topics: Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cushing Syndrome; Diabetes Mell

1995
Adrenal carcinoma.
    Current therapy in endocrinology and metabolism, 1994, Volume: 5

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aminoglutethimide; Carcinoma; Cushing Syndrome; Dia

1994
Effects of reserpine treatment on pituitary-adrenocortical axis in patients with Cushing's disease.
    Endocrine journal, 1993, Volume: 40, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adult; Circadian Rhythm; Cushing Syndrome; Depression, Chemic

1993
The metyrapone and dexamethasone suppression tests for the differential diagnosis of the adrenocorticotropin-dependent Cushing syndrome: a comparison.
    Annals of internal medicine, 1994, Sep-01, Volume: 121, Issue:5

    Topics: Adrenocorticotropic Hormone; Cortodoxone; Cushing Syndrome; Decision Trees; Dexamethasone; Diagnosis

1994
The Cushing syndrome: quest for the Holy Grail.
    Annals of internal medicine, 1994, Sep-01, Volume: 121, Issue:5

    Topics: Cushing Syndrome; Data Interpretation, Statistical; Dexamethasone; Humans; Metyrapone; Pituitary Fun

1994
Two patients with Cushing's disease in a kindred with multiple endocrine neoplasia type I.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 76, Issue:6

    Topics: Adolescent; Adult; Cushing Syndrome; Depressive Disorder; Dexamethasone; Female; Humans; Hyperparath

1993
Differential release of proopiomelanocortin-derived peptides from the human pituitary: evidence from a panel of two-site immunoradiometric assays.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 78, Issue:4

    Topics: Adrenocorticotropic Hormone; Adult; Aged; beta-Endorphin; beta-Lipotropin; Corticotropin-Releasing H

1994
An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    International urology and nephrology, 1993, Volume: 25, Issue:6

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adrenoc

1993
Stimulation by peptide histidine methionine (PHM) of adrenocorticotropin secretion in patients with Cushing's disease: a comparison with the effect of vasoactive intestinal peptide (VIP) and a study on the effect of combined administration of corticotropi
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 78, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethasone

1994
ACTH-independent Cushing's syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone.
    Clinical endocrinology, 1993, Volume: 39, Issue:3

    Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Delivery, Obstetric; Female; Humans; Hydrocort

1993
Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    The Journal of clinical investigation, 1993, Volume: 92, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Arginine

1993
Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia.
    The Journal of clinical endocrinology and metabolism, 1993, Volume: 76, Issue:1

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormon

1993
Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyrapone.
    Clinical endocrinology, 1993, Volume: 38, Issue:3

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Androstenedione; Blood Pressure; Cushin

1993
Use of metyrapone to treat pituitary-dependent hyperadrenocorticism in a cat with large cutaneous wounds.
    Journal of the American Veterinary Medical Association, 1993, Mar-15, Volume: 202, Issue:6

    Topics: Adrenalectomy; Adrenocortical Hyperfunction; Animals; Cat Diseases; Cats; Combined Modality Therapy;

1993
A comparison of the overnight and the standard metyrapone test for the differential diagnosis of adrenocorticotrophin-dependent Cushing's syndrome.
    Clinical endocrinology, 1996, Volume: 45, Issue:4

    Topics: ACTH Syndrome, Ectopic; Cortodoxone; Cushing Syndrome; Humans; Hydrocortisone; Metyrapone; Pilot Pro

1996
Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Clinical endocrinology, 1997, Volume: 46, Issue:5

    Topics: ACTH Syndrome, Ectopic; Adenoma; Adolescent; Adrenocorticotropic Hormone; Adult; Cortodoxone; Cushin

1997
[Night suppression with high doses of dexamethasone and metyrapone tests for the etiological diagnosis of Cushing syndrome].
    Medicina, 1996, Volume: 56, Issue:5 Pt 1

    Topics: Adolescent; Adult; Cushing Syndrome; Dexamethasone; Female; Humans; Male; Metyrapone; Middle Aged

1996
Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    Clinical endocrinology, 1997, Volume: 47, Issue:2

    Topics: Adolescent; Adult; Cortodoxone; Cushing Syndrome; Dexamethasone; Female; Glucocorticoids; Humans; Hy

1997
Early assessment of outcome of pituitary surgery for Cushing's disease.
    Clinical endocrinology, 1997, Volume: 47, Issue:2

    Topics: Cushing Syndrome; Humans; Hydrocortisone; Metyrapone; Pituitary Gland; Postoperative Period; Recurre

1997
Probability in practice in the diagnosis of Cushing's syndrome.
    Clinical endocrinology, 1997, Volume: 47, Issue:3

    Topics: Cushing Syndrome; Diagnosis, Differential; Humans; Metyrapone; Petrosal Sinus Sampling; Predictive V

1997
Cushing's syndrome due to bilateral adrenocortical adenomas with different pathological features.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:11

    Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adrenocorticotropic Hormone; Codon;

1997
[Cushing's syndrome: clinical study of fifteen cases].
    Anales de medicina interna (Madrid, Spain : 1984), 1998, Volume: 15, Issue:5

    Topics: Adult; Aged; Cushing Syndrome; Dexamethasone; Female; Humans; Hydrocortisone; Ketoconazole; Male; Me

1998
A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids.
    Endocrine journal, 1998, Volume: 45, Issue:4

    Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aged; Aldosterone; Cushing Syndrome; Dexamethasone; Glu

1998
Pregnancy-dependent Cushing's syndrome in three pregnancies.
    BJOG : an international journal of obstetrics and gynaecology, 2000, Volume: 107, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Female; Humans; Hydrocortisone; Metyrapone; Pr

2000
Cost-effectiveness and accuracy of the tests used in the differential diagnosis of Cushing's syndrome.
    Pituitary, 1999, Volume: 1, Issue:2

    Topics: ACTH Syndrome, Ectopic; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adrenocorticotropi

1999
Cushing's syndrome due to phaeochromocytoma secreting the precursors of adrenocorticotropin.
    The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:12

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Adult; alpha-MSH; Anti-Inflamma

2000
Involvement of the cholinergic pathway in the pathogenesis of pituitary Cushing's syndrome.
    Endocrine journal, 2001, Volume: 48, Issue:3

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenocorticotropic Hormone; Atropine; Choline;

2001
Rational, effective metyrapone treatment of ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH).
    Endocrine journal, 2001, Volume: 48, Issue:6

    Topics: Adrenal Glands; Cushing Syndrome; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Hydrocortiso

2001
The lethal form of Cushing's in 7B2 null mice is caused by multiple metabolic and hormonal abnormalities.
    Endocrinology, 2002, Volume: 143, Issue:6

    Topics: Adrenocorticotropic Hormone; Animals; Blood Glucose; Cause of Death; Corticosterone; Cushing Syndrom

2002
Metyrapone for Cushing's syndrome.
    The American journal of psychiatry, 2002, Volume: 159, Issue:7

    Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Enzyme Inhibitors; Humans; Hydrocortisone; Mal

2002
Endocrine and metabolic diseases. Adrenal diseases.
    British medical journal, 1976, Feb-21, Volume: 1, Issue:6007

    Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Insuffici

1976
Hormone secretion in alcohol-induced pseudo-Cushing's syndrome. Differential diagnosis with Cushing disease.
    JAMA, 1979, Oct-12, Volume: 242, Issue:15

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Cushing Syndrome; Dexamethasone; Diagnosis

1979
Cyproheptadine in Cushing's syndrome.
    Lancet (London, England), 1977, Sep-24, Volume: 2, Issue:8039

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Function Tests; Adult; Bromocriptine; Cushing Syndrome; Cy

1977
Pituitary function after removal of pituitary microadenomas in Cushing's disease.
    The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:2

    Topics: 17-Ketosteroids; Adenoma; Adult; Cushing Syndrome; Follicle Stimulating Hormone; Humans; Hydrocortis

1978
Studies of ACTH secretion control in 116 cases of Cushing's syndrome.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 40, Issue:2

    Topics: Adrenal Gland Diseases; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Biological Assay; Cushi

1975
[Adrenal cortex function tests].
    Duodecim; laaketieteellinen aikakauskirja, 1975, Volume: 91, Issue:7

    Topics: Addison Disease; Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Cushing Syndrome; Dexam

1975
ACTH-secreting 'apudoma' of gallbladder.
    Gut, 1975, Volume: 16, Issue:6

    Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Adult; Autopsy; Cushing Syndrome; Dexamethasone; Diagno

1975
[Paradoxical response of adrenal glands to dexamethasone in a case of adrenal carcinoma].
    MMW, Munchener medizinische Wochenschrift, 1975, May-30, Volume: 117, Issue:22

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenal Glands; Adrenocorticotr

1975
The diagnostic value of hypothalamic-pituitary-adrenocortical function tests in patients with Cushing's syndrome.
    Acta medica Okayama, 1975, Volume: 29, Issue:2

    Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Function Tests; Adrenal Gland Neoplasms; Adrenocorticotr

1975
Gastric carcinoid with ectopic production of ACTH and beta-MSH.
    Cancer, 1976, Volume: 37, Issue:1

    Topics: Adrenal Cortex Function Tests; Adrenocorticotropic Hormone; Carcinoma, Squamous Cell; Cushing Syndro

1976
Drug controlled of Cushing's syndrome. Combined aminoglutethimide and metyrapone therapy.
    Acta endocrinologica, 1976, Volume: 82, Issue:2

    Topics: Adrenocorticotropic Hormone; Aminoglutethimide; Cushing Syndrome; Dexamethasone; Drug Evaluation; Dr

1976
[Diagnostic problems in Cushing's syndrome during pregnancy].
    Die Medizinische Welt, 1976, Jun-04, Volume: 27, Issue:23

    Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Female; Humans; Hydrocortisone; Metyrapone; Pr

1976
Medullary thyroid carcinoma: ectopic production of peptides with ACTH-like, corticotrophin releasing factor-like and prolactin production-stimulating activities.
    Acta endocrinologica, 1976, Volume: 83, Issue:2

    Topics: Adrenocorticotropic Hormone; Antigens; Biological Assay; Calcitonin; Carcinoma; Corticotropin-Releas

1976
Periodic remission in Cushing's disease with paradoxical dexamethasone response: an expression of periodic hormonogenesis.
    The Journal of clinical endocrinology and metabolism, 1976, Volume: 43, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Adult; Cosyntropin; Cushing

1976
Ectopic ACTH syndrome due to salivary gland adenoid cystic carcinoma.
    Archives of internal medicine, 1977, Volume: 137, Issue:1

    Topics: Adrenocorticotropic Hormone; Aged; Autopsy; Carcinoma, Adenoid Cystic; Cushing Syndrome; Female; Hor

1977
[ACTH secretion and adrenocortical responsiveness in Cushing's syndrome due to adrenocortical hyperplasia (author's transl)].
    Nihon Naibunpi Gakkai zasshi, 1976, Aug-20, Volume: 52, Issue:8

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Cortex; Adrenal Glands; Adrenalectomy; Adrenocortical

1976
Assessment of 11beta-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol, and deoxycortisol: role of ACTH and angiotensin.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 44, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II;

1977
Metyrapone in long-term management of Cushing's disease.
    British medical journal, 1977, Jul-23, Volume: 2, Issue:6081

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Female; Hirsutism; Humans; Male; M

1977
Metyrapone is useful only as adjunctive therapy in Cushing's disease.
    Annals of internal medicine, 1978, Volume: 89, Issue:1

    Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Glucocorticoids; Humans; Metyrapone

1978
Surgical management of Cushing's syndrome.
    Surgery, 1978, Volume: 84, Issue:4

    Topics: Adenoma; Adolescent; Adrenal Cortex; Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocorticotropic Ho

1978
Plasma ACTH radioimmunoassays in the diagnosis of pituitary-adrenal dysfunction.
    Annals of the New York Academy of Sciences, 1977, Oct-28, Volume: 297

    Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Humans; Metyrap

1977
Hypertension induced by adrenocortical dysfunction--hypertension in 17 alpha-hydroxylase deficiency and metopirone-induced hypertension.
    Japanese circulation journal, 1978, Volume: 42, Issue:5

    Topics: Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Animals; Cushing Syndrome; Deso

1978
Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Clinical radiology, 1979, Volume: 30, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Age Factors; Aged; Aminoglutethimide; Cushing Syndrome; Female;

1979
Cushing's syndrome due to adrenocortical carcinoma - a comphrensive clinical and biochemical study of patients treated by surgery and chemotherapy.
    Acta endocrinologica, 1979, Volume: 91, Issue:2

    Topics: 17-Ketosteroids; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Aldosterone; Carcinoma; Cort

1979
Carcinoma of the lung presenting as Cushing's syndrome.
    The New Zealand medical journal, 1977, Jan-12, Volume: 85, Issue:579

    Topics: Aminoglutethimide; Carcinoma, Bronchogenic; Cortisone; Cushing Syndrome; Cyclophosphamide; Diagnosis

1977
Cushing's syndrome.
    Annals of the New York Academy of Sciences, 1977, Oct-28, Volume: 297

    Topics: Adenoma; Corticotropin-Releasing Hormone; Cushing Syndrome; Dexamethasone; Humans; Metyrapone; Pitui

1977
Evaluation of steroid laboratory tests and adrenal gland imaging with radiocholesterol in the aetiological diagnosis of Cushing's syndrome.
    Clinical endocrinology, 1979, Volume: 10, Issue:2

    Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Function Tests; Adrenal Glands; Adult; Aged; Cosyntropin

1979
The continued importance of adrenalectomy in the treatment of Cushing's disease.
    Archives of surgery (Chicago, Ill. : 1960), 1979, Volume: 114, Issue:4

    Topics: Adolescent; Adrenalectomy; Adult; Cushing Syndrome; Cyproheptadine; Female; Humans; Hypophysectomy;

1979
Metastatic medullary carcinoma of the thyroid complicated by Cushing's syndrome.
    The Medical journal of Australia, 1979, Mar-10, Volume: 1, Issue:5

    Topics: Adult; Aminoglutethimide; Carcinoma; Cushing Syndrome; Dexamethasone; Drug Therapy, Combination; Hum

1979
Specific radioimmunoassay of human beta-endorphin in unextracted plasma.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:3

    Topics: Adenoma; Adrenal Gland Neoplasms; Carcinoma, Bronchogenic; Cushing Syndrome; Dexamethasone; Endorphi

1979
Spontaneous remission of Cushing's disease. A case report and review of the literature.
    The American journal of medicine, 1979, Volume: 67, Issue:3

    Topics: Aged; Cushing Syndrome; Dexamethasone; Drug Therapy, Combination; Humans; Male; Metyrapone; Remissio

1979
[Metopirone loading test].
    Nihon rinsho. Japanese journal of clinical medicine, 1979, Jun-29, Volume: Suppl

    Topics: 17-Hydroxycorticosteroids; Cushing Syndrome; Humans; Metyrapone

1979
Evaluation of diagnostic and differential diagnostic tests in Cushing's syndrome.
    The Netherlands journal of medicine, 1977, Volume: 20, Issue:6

    Topics: Adult; Aged; Cushing Syndrome; Dexamethasone; Diagnosis, Differential; Evaluation Studies as Topic;

1977
Feminizing adrenocortical carcinoma with Cushing's syndrome and pseudohyperparathyroidism.
    Archives of internal medicine, 1978, Volume: 138, Issue:2

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult

1978
Radioimmunoassay of human beta-lipotropin in unextracted plasma.
    The Journal of clinical endocrinology and metabolism, 1977, Volume: 45, Issue:5

    Topics: Acromegaly; beta-Lipotropin; Cushing Syndrome; Female; Humans; Hypopituitarism; Immune Sera; Male; M

1977
Variation in response to dexamethasone of a patient with Cushing's syndrome.
    Canadian Medical Association journal, 1976, Nov-06, Volume: 115, Issue:9

    Topics: Adenoma, Chromophobe; Adult; Cortodoxone; Cushing Syndrome; Dexamethasone; Female; Humans; Hydrocort

1976
[Two cases of Cushing's disease with sudden remission after an episode of hysteria or administration of reserpine-metyrapone (author's transl)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1976, Volume: 65, Issue:9

    Topics: Adolescent; Cushing Syndrome; Female; Humans; Hysteria; Metyrapone; Reserpine

1976
Single-dose metyrapone test: review of a four-year experience.
    Archives of internal medicine, 1975, Volume: 135, Issue:5

    Topics: Adenoma, Chromophobe; Adolescent; Adrenal Cortex Neoplasms; Adrenal Gland Diseases; Adrenal Glands;

1975
The immunological hazard of Cushing's syndrome.
    British medical journal, 1975, Dec-20, Volume: 4, Issue:5998

    Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Cryptococcosis; Cushing Syndrome; Female; Fluorouracil; Hum

1975
Metyrapone test in Cushing's disease.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 40, Issue:3

    Topics: 17-Hydroxycorticosteroids; Administration, Oral; Adult; Cushing Syndrome; Evaluation Studies as Topi

1975
Testing adrenal function--1975.
    The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1975, Volume: 127, Issue:6

    Topics: Adolescent; Adrenal Cortex Function Tests; Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal

1975
Cushing's syndrome with fluctuation due to adrenal adenoma.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 41, Issue:2

    Topics: 11-Hydroxycorticosteroids; 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Circadian Rh

1975
[Effects of metyrapone administration on LH, FSH, TSH, and prolactin secretion].
    Horumon to rinsho. Clinical endocrinology, 1975, Volume: 23, Issue:6

    Topics: Cushing Syndrome; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Metyrapone; Prola

1975
[Functional tests used in diagnosis of different forms of hypercorticism].
    Sovetskaia meditsina, 1975, Issue:9

    Topics: Adrenal Glands; Adrenocortical Hyperfunction; Cushing Syndrome; Dexamethasone; Dihydroxyphenylalanin

1975
Paraneoplastic Cushing's syndrome as an adverse prognostic factor in patients who die early with small cell lung cancer.
    Cancer, 1992, Jan-01, Volume: 69, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Small Cell; Cushing Syndrome; Female; Humans; Lung Ne

1992
[ACTH-independent Cushing's syndrome due to bilateral macronodular adrenal hyperplasia with empty sella turcica and anterior panhypopituitarism].
    Revista clinica espanola, 1992, Volume: 190, Issue:5

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Aged; Cushing Syndrome; Empty Sella Syndrome; Humans; H

1992
Biochemical evaluation of adrenal dysfunction: the laboratory perspective.
    Mayo Clinic proceedings, 1992, Volume: 67, Issue:11

    Topics: Adolescent; Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Aged; Child; Cushing Syndrome

1992
Discordant changes in plasma ACTH and beta-lipotropin/beta-endorphin levels in Cushing's disease patients with depression.
    Psychoneuroendocrinology, 1992, Volume: 17, Issue:6

    Topics: Adrenocorticotropic Hormone; Adult; Aged; beta-Endorphin; beta-Lipotropin; Cushing Syndrome; Depress

1992
Cushing's syndrome induced by hypersecretion of cortisol from only one of bilateral adrenocortical tumors.
    Metabolism: clinical and experimental, 1992, Volume: 41, Issue:3

    Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Cortex Neoplasms; Adult; Cosyntropin; Cushing Syndrome; De

1992
A case of asymptomatic cortisol producing adrenal adenoma.
    Endocrinologia japonica, 1992, Volume: 39, Issue:1

    Topics: Adenoma; Adrenal Gland Neoplasms; Cushing Syndrome; Dexamethasone; Humans; Hydrocortisone; Hypothala

1992
Variable hormonogenesis in Cushing's syndrome.
    The Quarterly journal of medicine, 1991, Volume: 79, Issue:288

    Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dexamethasone; Dose-Response Relationship, Dru

1991
Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome.
    Clinical endocrinology, 1991, Volume: 35, Issue:2

    Topics: ACTH Syndrome, Ectopic; Adenoma; Adolescent; Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone;

1991
[A case of familial medullary carcinoma of the thyroid complicated with Cushing's syndrome].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1991, Jan-10, Volume: 80, Issue:1

    Topics: Adrenocorticotropic Hormone; Carcinoma; Circadian Rhythm; Cushing Syndrome; Dexamethasone; Humans; M

1991
Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    The Journal of clinical endocrinology and metabolism, 1990, Volume: 70, Issue:3

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cushing Syndrome; D

1990
Primary pigmented micronodular disease of the adrenals.
    Journal of endocrinological investigation, 1990, Volume: 13, Issue:2

    Topics: Adipose Tissue; Adolescent; Adrenal Cortex; Adrenal Medulla; Adrenocorticotropic Hormone; Cushing Sy

1990
An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing's syndrome by clinical features, biochemical tests and radiological findings.
    The Quarterly journal of medicine, 1990, Volume: 77, Issue:283

    Topics: ACTH Syndrome, Ectopic; Adolescent; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dexamethas

1990
Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome.
    The Journal of clinical endocrinology and metabolism, 1989, Volume: 68, Issue:4

    Topics: Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenalectomy; Adrenocorticotropic Hormone; Cushing

1989
A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing's syndrome.
    Clinical chemistry, 1989, Volume: 35, Issue:4

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Corticotropin-Releasing Hormone; Cosyntr

1989
[Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1989, Sep-20, Volume: 109, Issue:26

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Co

1989
Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up.
    Clinical endocrinology, 1989, Volume: 31, Issue:3

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Cushing Syndrome; Female; Follow-Up Studies; H

1989
[Clinical significance of urinary 17-hydroxycorticoid and its component analysis in endocrine tests of the adrenal cortex].
    Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 48 Suppl

    Topics: 17-Hydroxycorticosteroids; Addison Disease; Adolescent; Adrenal Cortex Function Tests; Adrenal Hyper

1989
Use of adrenal arterial embolization in severe ACTH-dependent Cushing's syndrome.
    Postgraduate medical journal, 1989, Volume: 65, Issue:766

    Topics: ACTH Syndrome, Ectopic; Adrenal Glands; Carcinoma; Combined Modality Therapy; Cushing Syndrome; Embo

1989
Cushing's syndrome due to huge nodular adrenocortical hyperplasia with fluctuation of urinary 17-OHCS excretion.
    Endocrinologia japonica, 1989, Volume: 36, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Cushing Syndrome; Dexamethasone; Humans; Hydrocortisone;

1989
[Adrenostatic treatment of ACTH-dependent Cushing syndrome using metyrapone and aminoglutethimide].
    Deutsche medizinische Wochenschrift (1946), 1987, Oct-02, Volume: 112, Issue:40

    Topics: Adolescent; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Aged; Aminoglutethimide; Cushing Syn

1987
Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone, and corticotropin-releasing factor.
    The American journal of medicine, 1988, Volume: 84, Issue:4

    Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Bronchial Neoplasms; Carcinoid Tumor; Co

1988
Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease.
    Acta endocrinologica, 1985, Volume: 109, Issue:1

    Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Animals; beta-Endorphin; Bromocriptine; Corticotropin-R

1985
Nocturnal high-dose dexamethasone suppression test in the aetiological diagnosis of Cushing's syndrome.
    Acta endocrinologica, 1985, Volume: 109, Issue:2

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Cortodoxone; Cushin

1985
Immunoreactive corticotropin-releasing factor in human plasma.
    The Journal of clinical investigation, 1985, Volume: 76, Issue:5

    Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Chromatography, High Pressure Liquid; Co

1985
Cushing's syndrome presenting the coexistence of a pituitary corticotrophic cell hyperplasia and a unilateral functional adrenal adenoma.
    Acta endocrinologica, 1985, Volume: 110, Issue:3

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Circadian Rhythm; Cush

1985
Hypothalamo-pituitary-adrenal axis in iatrogenic Cushing's syndrome.
    Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association, 1985, Volume: 84, Issue:8

    Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Adult; Aged; Cushing Syndrome; Fem

1985
Primary therapy for Cushing's disease with metyrapone.
    JAMA, 1986, Mar-07, Volume: 255, Issue:9

    Topics: Adolescent; Adrenocorticotropic Hormone; Circadian Rhythm; Cortodoxone; Cushing Syndrome; Drug Admin

1986
Alopecia associated with long-term metyrapone use.
    Clinical pharmacy, 1986, Volume: 5, Issue:1

    Topics: Adrenocorticotropic Hormone; Aged; Alopecia; Cushing Syndrome; Female; Humans; Metyrapone

1986
Successful control of Cushing's disease in the elderly with long term metyrapone.
    Postgraduate medical journal, 1986, Volume: 62, Issue:730

    Topics: Adrenocorticotropic Hormone; Age Factors; Aged; Cortodoxone; Cushing Syndrome; Female; Humans; Hydro

1986
Plasma ACTH in diagnosis and control of adrenal disorders.
    Acta endocrinologica. Supplementum, 1986, Volume: 279

    Topics: 17-alpha-Hydroxyprogesterone; Adenoma; Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Adre

1986
Cortisol responsiveness to insulin-induced hypoglycemia in Cushing's syndrome with huge nodular adrenocortical hyperplasia.
    Endocrinologia japonica, 1986, Volume: 33, Issue:4

    Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Angiotensin II; Arginine Vasopressin; Circadian Rhythm;

1986
Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 240, Issue:1

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenocorticotropic Hormone; Cortodoxone; Cushing Synd

1987
Plasma immunoreactive proopiomelanocortin peptides and cortisol in normal dogs and dogs with Cushing's syndrome: diurnal rhythm and responses to various stimuli.
    Endocrinology, 1988, Volume: 122, Issue:4

    Topics: Animals; Blood Glucose; Circadian Rhythm; Cushing Syndrome; Dexamethasone; Dogs; Dopamine; Female; H

1988
Totally automated liquid-chromatographic assay for cortisol and associated glucocorticoids in serum, with use of ASTED sample preparation.
    Clinical chemistry, 1988, Volume: 34, Issue:9

    Topics: Adrenal Hyperplasia, Congenital; Autoanalysis; Chromatography, High Pressure Liquid; Cushing Syndrom

1988
The corticotropin-releasing factor test in the diagnosis of ectopic ACTH secretion.
    The Western journal of medicine, 1987, Volume: 146, Issue:5

    Topics: ACTH Syndrome, Ectopic; Adenocarcinoma; Aged; Corticotropin-Releasing Hormone; Cushing Syndrome; Dex

1987
Cushing's syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:3

    Topics: ACTH Syndrome, Ectopic; Bronchial Neoplasms; Carcinoid Tumor; Corticotropin-Releasing Hormone; Cushi

1986
A competitive enzyme-linked immunosorbent assay for plasma 11-deoxycortisol (17,21-dihydroxy-4-pregnene-3,20-dione).
    Steroids, 1986, Volume: 47, Issue:6

    Topics: 17-Hydroxycorticosteroids; Animals; Cortodoxone; Cushing Syndrome; Enzyme-Linked Immunosorbent Assay

1986
Primary pigmented nodular adrenocortical disease: diagnosis and management.
    Surgery, 1986, Volume: 100, Issue:6

    Topics: Adolescent; Adrenal Cortex Diseases; Adrenalectomy; Adult; Child; Cushing Syndrome; Dexamethasone; D

1986
Metyrapone for depression and delirium secondary to Cushing's syndrome.
    Psychosomatics, 1985, Volume: 26, Issue:1

    Topics: Cushing Syndrome; Delirium; Depressive Disorder; Humans; Male; Metyrapone; Middle Aged

1985
Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy. Case report.
    British journal of obstetrics and gynaecology, 1985, Volume: 92, Issue:11

    Topics: Adult; Cushing Syndrome; Female; Humans; Hypertension; Metyrapone; Pregnancy; Pregnancy Complication

1985
Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 36, Issue:3

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocortical Hyperfunction; Adrenocorticotropic Hormon

1973
Remission of Cushing's disease after administration of adrenocorticotropin.
    The American journal of medicine, 1974, Volume: 57, Issue:6

    Topics: 17-Hydroxycorticosteroids; Administration, Oral; Adrenal Glands; Adrenal Insufficiency; Adrenocortic

1974
Deep sleep phase alterations in patients with loss of the adrenal secretory rhythm and in hypophysectomized patients. (The effects of hypothalamo-hypophyseal stressing by metopyron).
    Electroencephalography and clinical neurophysiology, 1967, Volume: 22, Issue:6

    Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Electroencephalography; Eye Movements;

1967
Patterns of urinary excretion of steroids in Cushing's syndrome.
    The Journal of clinical endocrinology and metabolism, 1966, Volume: 26, Issue:3

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Gland Neoplasms; Adrenocortical Hyperfunction; A

1966
Studies in a patient with an ectopic adrenocortical tumor.
    The Journal of clinical endocrinology and metabolism, 1966, Volume: 26, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adenocarcinoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotrop

1966
Intermittent Cushing's syndrome with anomalous response to dexamethasone.
    The Journal of endocrinology, 1966, Volume: 36, Issue:1

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethas

1966
Evaluation of the efficiency of 11-beta-hydroxylation of 11-deoxycortisol in human subjects.
    The Journal of clinical endocrinology and metabolism, 1967, Volume: 27, Issue:3

    Topics: Adrenal Glands; Adrenocorticotropic Hormone; Cushing Syndrome; Desoxycorticosterone; Estrogens; Huma

1967
Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
    Metabolism: clinical and experimental, 1967, Volume: 16, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenocortical Hyperfu

1967
Pituitary-adrenocortical studies in a patient with Cushing's syndrome induced by thymoma.
    The Journal of clinical endocrinology and metabolism, 1967, Volume: 27, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dex

1967
Epiandrosterone excretion in man.
    The Journal of endocrinology, 1967, Volume: 38, Issue:3

    Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Cushing Syndrome; Fem

1967
Cushing's syndrome in association with a carcinoid tumor of the lung.
    The Journal of clinical endocrinology and metabolism, 1967, Volume: 27, Issue:9

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Carcinoid Tumor; Cushing Sy

1967
Failure of metyrapone to inhibit 11-hydroxylation of 11-deoxycortisol during drug therapy.
    The Journal of clinical endocrinology and metabolism, 1967, Volume: 27, Issue:9

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Chromatography, Paper; Chrom

1967
The assessment of hypothalamic-pituitary-adrenocortical function in man.
    Proceedings of the Royal Society of Medicine, 1967, Volume: 60, Issue:9

    Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Female; Humans; Hydrocortisone; Insulin; Liver Diseas

1967
Cushing's syndrome associated with a "corticotrophin"-producing bronchial neoplasm neoplasm (results of corticotrophin assays and of pituitary-adrenal function tests).
    Acta endocrinologica, 1967, Volume: 56, Issue:2

    Topics: 17-Hydroxycorticosteroids; Adrenal Cortex Hormones; Adrenocortical Hyperfunction; Adrenocorticotropi

1967
Nycthemeral rhythm of plasma cortisol levels in the Cushing's syndrome associated with hyperplasia of adrenal cortex, before and after treatment of hypophyseal suppression with ultrasonic technique.
    Acta neurovegetativa, 1967, Volume: 30, Issue:1

    Topics: 17-Hydroxycorticosteroids; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Circadian Rhy

1967
Sequential solvent extraction of urinary corticosteroids and its clinical application.
    Clinical chemistry, 1967, Volume: 13, Issue:10

    Topics: 17-Hydroxycorticosteroids; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Adrenocorticotrop

1967
A fundamental defect of adrenocortical control in Cushing's disease.
    The Journal of endocrinology, 1968, Volume: 40, Issue:1

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Cortex Hormones; Adrenal Glands; Adrenalectomy; Adren

1968
[Intercurrent relationships between nyctohemeral rhythm of elimination of gonadotropins and adrenal cortex steroids].
    Folia endocrinologica, 1967, Volume: 20, Issue:2

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Circadian Rhythm; Cushing Syndrome; Dexameth

1967
[Functional evaluation of the pituitary gland with the metyrapone test and determination of ACTH in the blood].
    Folia endocrinologica, 1967, Volume: 20, Issue:2

    Topics: Acromegaly; Adrenal Insufficiency; Adrenocorticotropic Hormone; Cushing Syndrome; Humans; Hypopituit

1967
Cushing's syndrome caused by bronchial adenomas.
    The American journal of medicine, 1968, Volume: 44, Issue:1

    Topics: Adenoma; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Biological Assay; Bronchial Neoplasms; C

1968
[Patterns of adrenal steroids present in the blood].
    Nihon Naibunpi Gakkai zasshi, 1967, Oct-20, Volume: 43, Issue:7

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Aldosterone; Blood Proteins; Corticosterone; C

1967
Successful metyrapone therapy of the ectopic ACTH syndrome.
    Archives of internal medicine, 1968, Volume: 121, Issue:6

    Topics: Adolescent; Adrenocorticotropic Hormone; Biopsy; Carcinoma; Cushing Syndrome; Cyclophosphamide; Horm

1968
Hypothalamo-pituitary-adrenal function in hypercorticosteroid states.
    Acta endocrinologica, 1968, Volume: 58, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dexamethasone; Feed

1968
[Pituitary syndromes of diencephalic origin. Clinical application of pituitary stimulation tests].
    Schweizerische medizinische Wochenschrift, 1968, Feb-03, Volume: 98, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adrenal Gland Diseases; Adrenal Insufficiency; Adrenocorticotropic Hormon

1968
[Progress in the clinical pathology of the adrenal cortex].
    Zentralblatt fur Chirurgie, 1967, Volume: 92, Issue:26a Pt 1

    Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Child; Cushing Synd

1967
Vasopressin in the evaluation of pituitary-adrenal function.
    Annals of internal medicine, 1968, Volume: 69, Issue:2

    Topics: Acromegaly; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Anorex

1968
Medullary carcinoma of the thyroid--a cause of Cushing's syndrome: report of two cases.
    The Journal of clinical endocrinology and metabolism, 1968, Volume: 28, Issue:8

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Carci

1968
Radioimmunoassay of ACTH in plasma.
    The Journal of clinical investigation, 1968, Volume: 47, Issue:12

    Topics: 17-Hydroxycorticosteroids; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Con

1968
[Endoccinological changes as a result of obesity in juveniles].
    Der Internist, 1968, Volume: 9, Issue:4

    Topics: Adolescent; Adrenocorticotropic Hormone; Age Factors; Blood Glucose; Body Height; Body Weight; Cushi

1968
Cushing's syndrome induced by the ectopic production of ACTH by a bronchial carcinoid.
    The Journal of clinical endocrinology and metabolism, 1969, Volume: 29, Issue:1

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Aged; Bronchial Neoplasms;

1969
A simple method for the separate estimation of 11-deoxy and 11-oxygenated 17-hydroxycortico-steroids in human urine.
    The Journal of endocrinology, 1968, Volume: 41, Issue:2

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Gland Neoplasms; Adrenal Hyperplasia, Congenital; Adr

1968
[Functional exploration of the adrenal cortex in basal and dynamic conditions in hypercorticism of the Cushing type].
    Folia endocrinologica, 1968, Volume: 21, Issue:3

    Topics: 17-Ketosteroids; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocortical Hyperfu

1968
[Clinical studies on the stimulation and suppression of the pituitary-adrenocortical system. II. Studies on the pituitary-adrenocortical suppression test].
    Nihon Naibunpi Gakkai zasshi, 1968, Dec-20, Volume: 44, Issue:9

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; C

1968
[Present state of the dynamic studies of the adrenal cortex (excepting and aldosterone function)].
    La Presse medicale, 1968, Nov-23, Volume: 76, Issue:45

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Addison Disease; Adrenal Gland Neoplasms; Adrenal Insuff

1968
[Fractional determination of 4 types of neutral steroid glucuronides (11-deoxy-C-19 steroid, 11-deoxy-C-21 steroid, 11-oxy-C-19 steroid, 11-oxy-C-21 steroid) and 3 types of steroid glucuronides (11-deoxy-neutral steroid, pregnanediol, 11-oxy-neutral stero
    Nihon Naibunpi Gakkai zasshi, 1969, Jan-20, Volume: 44, Issue:10

    Topics: Adrenal Insufficiency; Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; Castration;

1969
Metyrapone and pyrogen tests in hyperadrenocorticism: evaluation of blood corticotropin levels.
    The Journal of endocrinology, 1968, Volume: 42, Issue:2

    Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Animals; Biological Assay; Corticosterone; Cushing S

1968
Normal and abnormal regulation of beta-msh in man.
    The Journal of clinical investigation, 1969, Volume: 48, Issue:8

    Topics: Addison Disease; Adolescent; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenal Hyperplasia, C

1969
Diagnosis of Cushing's syndrome. The differentiation between adrenocortical hyperplasia and adrenocrotical adenoma by means of lysine-vasopressin.
    Acta endocrinologica, 1969, Volume: 60, Issue:1

    Topics: 17-Hydroxycorticosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone

1969
Radioimmunoassayable ACTH in dexamethasone nonsuppressible Cushing's syndrome.
    The Journal of clinical endocrinology and metabolism, 1969, Volume: 29, Issue:9

    Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Adult; Chemistry, Clinical; Cushing Syndr

1969
[Evaluation of the pituitary ACTH reserve in patients irradiated for cerebral neoplasms].
    Nuntius radiologicus, 1968, Volume: 34, Issue:5

    Topics: Acromegaly; Adrenocorticotropic Hormone; Adult; Astrocytoma; Brain Neoplasms; Cushing Syndrome; Fema

1968
Cushing's syndrome with a paradoxical response to dexamethasone.
    The American journal of medicine, 1969, Volume: 47, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adenoma, Basophil; Adrenalectomy; Adrenocortical Hyperfu

1969
[Diurnal variation of plasma cortisol concentration in patients with various diseases and negative feedback mechanism of the pituitary-adrenal axis].
    Nihon Naibunpi Gakkai zasshi, 1969, Sep-20, Volume: 45, Issue:6

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Central Nervous Sys

1969
Anomalous response to metyrapone in Cushing's syndrome due to adrenocortical adenoma.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 30, Issue:1

    Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Cus

1970
Evaluation of stimulation and suppression tests in the etiological diagnosis of Cushing's syndrome.
    Annals of internal medicine, 1969, Volume: 71, Issue:5

    Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Ang

1969
[Broncho-pulmonary cancer with true or degraded hypercorticism].
    La Presse medicale, 1969, Nov-29, Volume: 77, Issue:51

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocortical Hyperfunction; Adrenocorticotropic Hormon

1969
"Cure" of ectopic ACTH syndrome secondary to adrenocarcinoma of the lung.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 30, Issue:5

    Topics: 17-Ketosteroids; Acid Phosphatase; Adenocarcinoma; Adrenocorticotropic Hormone; Cushing Syndrome; Cy

1970
[Gas liquid chromatography analysis of urinary neutral steroid fractions in normal persons and patients with various diseases].
    Nihon Naibunpi Gakkai zasshi, 1970, Jun-20, Volume: 46, Issue:3

    Topics: 17-Ketosteroids; Adrenal Gland Diseases; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormon

1970
[Diagnosis and management of Cushing' syndrome based on our 28 cases, with special reference to combined therapy of 60Co irradiation of the hypothalamus and reserpine].
    Nihon rinsho. Japanese journal of clinical medicine, 1970, Volume: 28, Issue:4

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Child; Cobalt Isotopes; C

1970
Cushing's syndrome caused by a metyrapone responsive adrenocortical adenoma.
    The Journal of clinical endocrinology and metabolism, 1970, Volume: 31, Issue:2

    Topics: 17-Hydroxycorticosteroids; Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Horm

1970
Tests in cushing's syndrome.
    Annals of internal medicine, 1970, Volume: 72, Issue:5

    Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Humans; Metyrapone

1970
Cushing's syndrome, a personal view.
    British medical journal, 1970, Aug-29, Volume: 3, Issue:5721

    Topics: Adrenocorticotropic Hormone; Cushing Syndrome; Feedback; Humans; Hydrocortisone; Metyrapone; Stress,

1970
[Poly-micro-adenomatosis in Cushing's syndrome].
    La Presse medicale, 1970, Oct-17, Volume: 78, Issue:43

    Topics: Adenoma; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Cushing Syndr

1970
[Biochemical diagnosis of adrenal cortex function].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1970, Nov-01, Volume: 90, Issue:21

    Topics: Adrenal Cortex Hormones; Adrenal Gland Diseases; Adrenal Gland Neoplasms; Adrenocorticotropic Hormon

1970
[Diagnosis of Cushing's syndrome].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1970, Oct-20, Volume: 59, Issue:42

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dexamethasone; Diag

1970
[Correlation of ACTH and MSH in man].
    Nihon Naibunpi Gakkai zasshi, 1970, Volume: 46, Issue:8

    Topics: Addison Disease; Adrenocorticotropic Hormone; Cross Reactions; Cushing Syndrome; Hormones, Ectopic;

1970
Cushing's syndrome caused by malignant tumor in the scrotum: clinical, pathologic and biochemical studies.
    The Journal of clinical endocrinology and metabolism, 1971, Volume: 32, Issue:2

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Rest Tumor; Adrenocorticotropic Hormone; Androst

1971
[Pituitary corticotropin function in hypertonic obesity "with rose striae"].
    Folia endocrinologica, 1970, Volume: 23, Issue:1

    Topics: Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Diagnosis, Differential; Female; Humans; Hyper

1970
A new phenomenon of usefulness in the radioimmunoassay of plasma adrenocorticotropic hormone.
    The Journal of laboratory and clinical medicine, 1971, Volume: 77, Issue:3

    Topics: Addison Disease; Administration, Oral; Adrenalectomy; Adrenocorticotropic Hormone; Circadian Rhythm;

1971
[Radioimmunoassay of ACTH].
    Nihon Naibunpi Gakkai zasshi, 1971, May-20, Volume: 47, Issue:2

    Topics: 17-Hydroxycorticosteroids; Addison Disease; Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Ho

1971
Results of treatment in 108 patients with Cushing's syndrome.
    The New England journal of medicine, 1971, Jul-29, Volume: 285, Issue:5

    Topics: Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Age

1971
Therapeutic possibilities in Cushing's syndrome.
    The New England journal of medicine, 1971, Jul-29, Volume: 285, Issue:5

    Topics: Adrenalectomy; Adrenocorticotropic Hormone; Aminoglutethimide; Cushing Syndrome; Hormones, Ectopic;

1971
[Cushing's syndrome].
    Naika. Internal medicine, 1971, Volume: 27, Issue:6

    Topics: Adolescent; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dexametha

1971
Detection of an ACTH-secreting bronchial carcinoid tumour eighteen months after adrenalectomy for Cushing's syndrome.
    Acta endocrinologica, 1971, Volume: 67, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Bronc

1971
[Pituitary function test using synthetic lysine-8-vasopressin--comparison with metopirone test and insulin stress test].
    Naika. Internal medicine, 1971, Volume: 28, Issue:1

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anorexia Nervosa; Craniopharyngioma; Cushing S

1971
[Study of plasma ACTH in 100 human lysine-vasopressin tests].
    Acta endocrinologica, 1971, Volume: 68, Issue:1

    Topics: Addison Disease; Adolescent; Adrenal Gland Diseases; Adrenal Glands; Adrenalectomy; Adrenocorticotro

1971
Tests of adrenocortical function.
    The New England journal of medicine, 1971, Nov-18, Volume: 285, Issue:21

    Topics: Adrenal Gland Neoplasms; Adrenal Insufficiency; Adrenocorticotropic Hormone; Cushing Syndrome; Dexam

1971
Size heterogeneity of immunoreactive human ACTH in plasma and in extracts of pituitary glands and ACTH-producing thymoma.
    Biochemical and biophysical research communications, 1971, Jul-16, Volume: 44, Issue:2

    Topics: Addison Disease; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Antigens; Chromatography, Gel;

1971
A comparison of bioassay and radioimmunoassay for plasma corticotropin in man.
    The Journal of clinical endocrinology and metabolism, 1972, Volume: 34, Issue:4

    Topics: Addison Disease; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Animals; Antigens; Biol

1972
[Behavior of adrenocorticotropic internal secretions in Cushing's syndrome].
    Schweizerische medizinische Wochenschrift, 1970, Oct-03, Volume: 100, Issue:40

    Topics: 17-Hydroxycorticosteroids; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Circadian Rhythm; Cu

1970
Recurrent Cushing's disease following "total" adrenalectomy.
    Archives of internal medicine, 1972, Volume: 129, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormo

1972
[Function studies of the hypothalamus-anterior-pituitary-adrenal cortex system following surgery of cortisol-producing adrenal gland adenoma].
    Deutsche medizinische Wochenschrift (1946), 1972, Aug-04, Volume: 97, Issue:31

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adrenal Insufficienc

1972
Extra-adrenal action of metyrapone upon human growth hormone secretion in man.
    Endocrinologia japonica, 1972, Volume: 19, Issue:2

    Topics: Addison Disease; Adrenalectomy; Adrenocorticotropic Hormone; Blood Glucose; Cushing Syndrome; Growth

1972
Measurement of pituitary hormones: clinical applications. 2. Corticotrophin.
    The New Zealand medical journal, 1972, Volume: 75, Issue:481

    Topics: Addison Disease; Adrenal Gland Diseases; Adrenocorticotropic Hormone; Circadian Rhythm; Cushing Synd

1972
Cushing's disease with periodic hormonogenesis: one explanation for paradoxical response to dexamethasone.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 36, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adrenocorticotropic Hormone; Cushing Syndrome; Dexamethasone; Dihydroxyph

1973
[Diagnosis and therapy of endogenic hypercortisolism (Cushing's syndrome)].
    Zeitschrift fur arztliche Fortbildung, 1972, Oct-15, Volume: 66, Issue:20

    Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Cushing Syndrome; Dexamethasone; Diagnosis, Diffe

1972
[Medical therapy of hyperadrenalism].
    Minerva medica, 1973, Mar-14, Volume: 64, Issue:14

    Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Aminoglutethimide; Cushing Syndrome; Huma

1973
[Urinary 6beta-hydroxycortisol. II. Urinary 6beta-hydroxycortisol in different diseases and after administration of drugs].
    Nihon Naibunpi Gakkai zasshi, 1973, Jun-20, Volume: 49, Issue:6

    Topics: Adenoma; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Carcinoma; Cushing Syndrome; F

1973
Iatrogenic Cushing's disease in a boy after misdiagnosis of salt-losing virilizing adrenal hyperplasia: impaired metyrapone response with failure of catch-up growth.
    The Journal of pediatrics, 1973, Volume: 83, Issue:1

    Topics: 17-Ketosteroids; Adrenal Hyperplasia, Congenital; Adrenal Insufficiency; Adrenocorticotropic Hormone

1973
[Importance of the study of corticotropin circadian rhythm in the functional symptomatology of the ACTH-adrenal axis].
    Minerva medica, 1974, Jun-16, Volume: 65, Issue:46

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenocorticotropic Hormone; Adult; Anorexia Nervosa; Cir

1974
Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man.
    Klinische Wochenschrift, 1974, Jun-01, Volume: 52, Issue:11

    Topics: Addison Disease; Adrenalectomy; Adrenocorticotropic Hormone; Cushing Syndrome; Humans; Lysine; Metho

1974
Cushing's disease with cure by resection of a pituitary adenoma. Evidence against a primary hypothalamic defect.
    The American journal of medicine, 1974, Volume: 57, Issue:5

    Topics: Adenoma; Adrenocorticotropic Hormone; Adult; Circadian Rhythm; Cushing Syndrome; Depression, Chemica

1974
Treatment of Cushing's disease with adrenal blocking drugs and megavoltage therapy to the pituitary.
    Proceedings of the Royal Society of Medicine, 1974, Volume: 67, Issue:12 Pt 1

    Topics: Adrenal Gland Diseases; Adrenocorticotropic Hormone; Adult; Aminoglutethimide; Cushing Syndrome; Fem

1974
The adrenal cortex (excluding aldosteronism).
    Clinics in endocrinology and metabolism, 1974, Volume: 3, Issue:3

    Topics: 17-Ketosteroids; Addison Disease; Adrenal Cortex; Adrenal Gland Diseases; Adrenal Glands; Adrenocort

1974
Cushing's syndrome with dual pituitary-adrenal control.
    Archives of internal medicine, 1970, Volume: 125, Issue:6

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Adrenalectomy; Adrenocorticotropic Hormone; Adult; Cushin

1970
Cytochrome P450 and steroid 11beta-hydroxylation in mitochondria from human adrenal cortex.
    The Journal of clinical endocrinology and metabolism, 1968, Volume: 28, Issue:8

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Antimycin A; Breast Neoplasms; Carbon Monoxide; Cushing S

1968
[Urinary steroids under the effect of standardized dynamic tests].
    Studii si cercetari de endocrinologie, 1972, Volume: 23, Issue:2

    Topics: Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Adult; Chorionic Gonadotropin; Cryptorchidism;

1972
[Proceedings: Cushing's syndrome in hypernephroid carcinoma; normalization of the cortisol value, hypokalemia and hypertension under metopirone].
    Helvetica medica acta, 1974, Volume: 37, Issue:5-6

    Topics: Adenocarcinoma; Cushing Syndrome; Humans; Hydrocortisone; Hypertension; Hypokalemia; Kidney Neoplasm

1974
Use of corticosteroids.
    Southern medical journal, 1974, Volume: 67, Issue:11

    Topics: Addison Disease; Administration, Oral; Adolescent; Adrenocortical Hyperfunction; Age Factors; Asthma

1974
[Endocrine regulation of adrenal function (author's transl)].
    Revista medica de Chile, 1974, Volume: 102, Issue:8

    Topics: Addison Disease; Circadian Rhythm; Cushing Syndrome; Dexamethasone; Humans; Hypothalamo-Hypophyseal

1974
Diagnostic and therapeutic problems in spontaneous Cushing's syndrome. A review with five case reports.
    Scandinavian journal of urology and nephrology, 1972, Volume: 6

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adrenalectomy; Adult; Circadian Rhythm;

1972
Temporal rhythm in the response of urinary 17-OHCS to metopirone in Cushing's syndrome due to bilateral adrenal hyperplasia.
    The Journal of clinical endocrinology and metabolism, 1973, Volume: 36, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adrenal Glands; Circadian Rhythm; Cushing Syndrome; Feedback; Female; Hum

1973
Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.
    The Quarterly journal of medicine, 1973, Volume: 42, Issue:165

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Glands; Adult; Blood Proteins; Child; Creatinine

1973
An assessment of the metyrapone test.
    Clinical endocrinology, 1973, Volume: 2, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Chromatography, Gas; Cushing Syndrome; Diagnosis, Differential

1973
Cushing's syndrome due to bilateral adrenal cortical hyperplasia in a 13-year old girl: successful treatment with op'DDD'.
    Helvetica paediatrica acta, 1974, Volume: 29, Issue:3

    Topics: 17-Ketosteroids; Adolescent; Adrenal Cortex Hormones; Adrenal Gland Diseases; Body Height; Body Weig

1974
Cushing's disease in a boy: serial steroid and growth hormone studies.
    The Johns Hopkins medical journal, 1969, Volume: 125, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adrenalectomy; Arginine; Child; Cushing Syndrome; Dexamethasone; Diagnosi

1969
Persistent or recurrent Cushing's syndrome after "total" adrenalectomy: adrenal photoscanning for residual tissue.
    Archives of internal medicine, 1972, Volume: 130, Issue:3

    Topics: 17-Hydroxycorticosteroids; Adrenalectomy; Adult; Cholesterol; Cushing Syndrome; Dexamethasone; Femal

1972
Immediate effect of unilateral adrenalectomy followed by external pituitary irradiation on cortisol secretion rate in subjects suffering from pituitary dependent Cushing's syndrome.
    The Journal of clinical endocrinology and metabolism, 1971, Volume: 33, Issue:6

    Topics: Adrenalectomy; Adult; Cushing Syndrome; Dexamethasone; Female; Follow-Up Studies; Humans; Hydrocorti

1971
Excretion of urinary free amino acids in Cushing's syndrome.
    The Journal of clinical endocrinology and metabolism, 1969, Volume: 29, Issue:12

    Topics: 17-Hydroxycorticosteroids; Adenoma; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Amino

1969
Tests of hypothalamic-pituitary-adrenal function in man.
    The Quarterly journal of medicine, 1969, Volume: 38, Issue:152

    Topics: Acromegaly; Adrenal Glands; Adult; Aged; Cushing Syndrome; Female; Fever; Glucocorticoids; Growth Ho

1969
[Diagnosis of disturbances of adrenal cortex function].
    Zeitschrift fur Allgemeinmedizin, 1969, Dec-31, Volume: 45, Issue:36

    Topics: 17-Hydroxycorticosteroids; Addison Disease; Adolescent; Adrenal Cortex Hormones; Adult; Cushing Synd

1969
Use of lysin-vasopressin in the differential diagnosis of cushing's syndrome.
    Acta endocrinologica, 1970, Volume: 65, Issue:4

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Cushing Syndrome; Diagnosis, Differential; Female; Hu

1970
[2 cases of Cushing's disease with a hypokalemic alkalosis syndrome].
    La Revue lyonnaise de medecine, 1967, Nov-15, Volume: 16, Issue:17

    Topics: Adrenalectomy; Adult; Alkalosis; Calcium; Cushing Syndrome; Female; Humans; Hypokalemia; Metyrapone;

1967
[Hypothalamo-hypophyseo-adrenocortical response to insulin-induced hypoglycemia].
    Nihon Naibunpi Gakkai zasshi, 1967, Nov-20, Volume: 43, Issue:8

    Topics: Acromegaly; Adenoma, Chromophobe; Adrenal Cortex Hormones; Adult; Blood Glucose; Craniopharyngioma;

1967
[Clinical studies on urinary 17-ketogenic steroid fractions. 3. SU-4885 test in normal subjects and the patients with various endocrine disorders].
    Nihon Naibunpi Gakkai zasshi, 1968, Mar-20, Volume: 43, Issue:12

    Topics: 17-Hydroxycorticosteroids; Acromegaly; Adenoma; Adolescent; Adrenal Cortex Hormones; Adrenal Gland N

1968
[Differentiated evaluation of metopirone test by thin layer chromatography].
    Klinische Wochenschrift, 1968, Feb-15, Volume: 46, Issue:4

    Topics: Addison Disease; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Chromatography, Thin Layer

1968
A simplified metyrapone test with determination of plasma ll-deoxycortisol (Metyrapone test with plasma S).
    The Journal of clinical endocrinology and metabolism, 1969, Volume: 29, Issue:7

    Topics: 17-Hydroxycorticosteroids; Adrenal Gland Neoplasms; Adrenal Insufficiency; Adrenocortical Hyperfunct

1969
Cushing's syndrome in infancy.
    The Journal of pediatrics, 1969, Volume: 75, Issue:3

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Abnormalities, Multiple; Adenoma; Adrenal Gland Neoplasm

1969
[Anterior pituitary lobe activity and demonstration of an exophthalmos producing factor (EPF) in serum].
    Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1965, Volume: 71

    Topics: Cushing Syndrome; Endocrine System Diseases; Exophthalmos; Humans; Metyrapone; Pituitary Gland; Thyr

1965
[Treatment of Cushing's syndrome].
    Deutsche medizinische Wochenschrift (1946), 1966, Jan-28, Volume: 91, Issue:4

    Topics: Cushing Syndrome; Dexamethasone; Humans; Hypophysectomy; Metyrapone; Pituitary Irradiation

1966
Some factors determining the adrenal response to metyrapone (SU 4885).
    Clinical science, 1966, Volume: 30, Issue:2

    Topics: Cushing Syndrome; Desoxycorticosterone; Humans; Hydrocortisone; Metyrapone; Pituitary-Adrenal Functi

1966
Failure of dexamethasone suppression in adrenal hyperplasia.
    Archives of internal medicine, 1966, Volume: 118, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Cushing Syndrome; Dexamethasone; Diagnosis, Differential; Humans; Hy

1966